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ABSTRACT 
Synaptosomal-associated protein of 25 kDa (SNAP-25) is a protein that participates in the 
regulation of synaptic vesicle exocytosis and modulates voltage-gated calcium channels 
activity. Altered levels of SNAP-25 expression have been associated to different 
neurological and neuropsychiatric conditions, such as schizophrenia, ADHD, and bipolar 
disorder, and lower levels of SNAP-25 have been described in patients with schizophrenia. 
I used Snap-25 heterozygous (Snap-25
+/−
) mice, expressing reduced levels of SNAP-25, to 
investigate at which extent the reduction of the protein expression affects neuronal network 
function and mouse behaviour. Snap-25
+/−
 mice displayed a moderate hyperactivity, which 
disappeared in the adult animals and showed an impairment in associative learning and 
recognition memory. Electroencephalographic recordings revealed the occurrence of 
frequent spikes, suggesting a diffuse network hyperexcitability. Moreover, SNAP-25
+/−
 
mice displayed higher susceptibility to kainate-induced seizures. Notably, treatment with 
antiepileptic drugs improve both EEG profile and cognitive defects. The abnormal EEG 
profile observed in SNAP-25
+/-
 mice could contribute to the learning and memory defects. 
Based on the results i have obtained, showing the occurrence of cognitive disabilities in 
mice expressing reduced levels of SNAP-25, i conducted a functional analysis on SNP 
rs363050, which associates with low performance IQ and is located on  intron 1 of the 
Snap-25 gene, to investigate whether the presence of the parental or minor allele may 
affect the expression of SNAP-25. The presence of minor allele resulted in a reduction of 
the transcription capability, while the parental allele did not increase the basal activity of 
an heterologous promoter. These results indicate that reduction of SNAP-25 expression is 
associated to generation of epileptiform discharges and cognitive dysfunctions, which can 
be effectively treated by antiepileptic drugs and support the evidence that the rs363050 
polymorphism might have a role in modulating Snap-25 gene expression levels. 
 
  
2 
 
INTRODUCTION 
THE SYNAPSE 
In the central nervous system communication between neurons occurs in site termed 
synapses. The term synapse was originally introduced more than 100 years ago by Charles 
Sherrington and was then later adopted by Ramòn Cajal. However, since the introduction 
of electron microscopy and related techniques that allow subcellular and molecular 
resolution, our knowledge about these structures has steadily increased over the last 50 
years. Synapses are the key elements for signal transduction and plasticity in the brain; 
chemical synapses are specialized sites of information exchange between neurons and their 
target cells. At the synapse, the arriving electrical signal is rapidly and efficiently 
transformed into a chemical signal through the regulated exocytosis of neurotrasmitter-
filled synaptic vesicles. The most common arrangement is either the axo-dendritic or the 
axo-somatic synapse, in which the axon of the cell of origin makes its functional contact 
with the dendrites or the soma of the target neuron; contacts between adjacent cell bodies 
(soma-somatic) or overlapping dendrites (dendro-dendritic) are more rare. 
Each synapse is a complex of several components: a presynaptic element, a cleft and a 
postsynaptic element. The presynaptic element, named bouton, is characterised by the 
presence of synaptic vesicles and a presynaptic thickening at the active zone; in this region, 
at any time a small number of vesicles are docked and presumably ready for fusion. The 
active zone is also enriched with voltage gated calcium channels (VGCCs), which are 
necessary to permit activity-dependent fusion and neurotransmitter release. The synaptic 
cleft is an essential space between the presynaptic and the postsynaptic elements; the width 
of the cleft (~20 µm) defines the volume in which the vesicles release its content, and 
therefore the peak concentration of the neurotransmitter upon release. On the flanks of the 
synapse, the cleft is spanned by adhesion molecules which are believed to stabilize the 
cleft (Fig. 1). The postsynaptic element is usually a portion of a soma or a dendrite, or 
rarely a part of an axon. It is marked by the presence of a thickening named postsynaptic 
density (PSD), which is associated with neurotransmitter receptors (e.g. NMDA glutamate 
receptors) and other molecules (e.g. the protein PSD95).  
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Figure 1. The synapses. (A) Schematic rappresentation of the synaspe. (B) Electron microscopy image of a 
synaptic bouton and the postsynaptic density (C) (from Sudhof 2012). 
 
Synaptic transmission is initiated when an action potential reaches the presynaptic 
terminal, which depolarises the membrane in the synapse that leads to opening of voltage-
gated Ca
2+
 channels. This causes a rapid influx of Ca
2+
 into the presynaptic terminal. This 
elevation of the intracellular Ca
2+
 concentration stimulates synaptic vesicles to fuse with 
the presynaptic membrane. In most synapses, release is stimulated by Ca
2+
 influx through 
P/Q- (CaV2.1) or N- (CaV2.2) type Ca
2+
 channels, whereas the related R- (CaV2.3) or the 
more distant L- (CaV1 series) type Ca
2+
 channels  are involved only rarely (see Dietrich, 
2003). Even at rest, synapses have a finite but low probability of release, causing 
spontaneous events of exocytosis that are reflected in electrophysiological recordings as 
miniature postsynaptic currents (Katz, 1969). Ca
2+
 influx triggers at least two components 
of release that are probably mechanistically distinct: a fast, synchronous phasic component 
is induced rapidly, in as little as 50 µsec after a Ca
2+
 transient develops (Sabatini and 
Regehr, 1996), and a lower asynchronous component continues for >1 sec, as an increase 
in the rate of spontaneous release after the action potential (Barrett and Stevens, 1972; 
Geppert et al. 1994; Goda and Stevens, 1994; Atluri and Regehr, 1998). Both components 
of release are strictly Ca
2+
 dependent.  
Neurotransmitter release requires the fusion of synaptic vesicles with the surface 
membrane at the active zones, thereby releasing their contents (exocytosis); after this event, 
vesicles are re-endocytosed, recycled, and refilled with neurotransmitters. When a nerve 
terminal is stimulated, not all vesicles can be released immediately because synaptic 
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vesicles exist in functionally different pools. There are three distinct pools of vesicles: a 
readily-releasable pool (RRP) characterized by a small cluster of vesicles (10+) at the 
active zone, ready for release, a recycling pool (100+ vesicles) that supplies vesicles to the 
RRP, and a large reserve pool (several hundred vesicles) that supplies vesicles to the 
recycling pool (Rizzoli and Betz, 2004). At rest, molecules called synapsins tether reserve 
pool synaptic vesicles to the cytoskeleton. Upon strong stimulation, high calcium ion 
concentration in the terminal triggers the phosphorylation of synapsins; as a consequence, 
synaptic vesicles are released  from the cytoskeleton and can move to the membrane and 
be primed for release. 
The fusion of synaptic vesicles with the plasma membrane is under tight temporal and 
spatial control as synaptic vesicles only dock, fuse and release neurotrasmitters at a 
restricted and highly specialized area of the presynaptic plasma membrane called the active 
zone; this area is tightly associated with an electron dense cytoskeletal matrix, which is 
referred to as cytomatrix at the active zone (CAZ). Ultrastructural studies of synapses have 
revealed that the presynaptic active zone is closely and precisely aligned with the PSD and 
that the plasma membranes on both sites of the synaptic cleft appears as electron-dense 
structures, suggesting their proteinaceous nature. A variety of proteins have been identified 
that are associated with the CAZ, most of which are not restricted to active zone but can 
also be found in other compartments of the cell. Amomg these, proteins involved in 
synaptic vesicle fusion (syntaxin, SNAP-25, Munc18), cytoskeletal proteins (actin, tubulin, 
myosin, spectrin, β-catenin), scaffolding proteins (CASK, Mint, SAP97 and velis/MALS), 
voltage-gated calcium channels (VGCCs) and cell adhesion molecules (neurexin, 
cadherins, integrins and sidekicks). Emerging evidence suggests that five evolutionarily 
conserved proteins, RIM, Munc13, RIM-BP, α-liprin, and ELKS proteins form the core of 
active zones. In addition to these five core active zone proteins, piccolo and bassoon (two 
large homologous proteins) are associated in vertebrates with active zones (Dieck et al. 
1998; Wang et al. 1999; Fenster et al. 2000; Limbach et al. 2011). These proteins form an 
interconnected network that is linked to synaptic vesicles, cytoskeletal proteins and 
calcium channels and are instrumental for the integration and organization of distinct steps 
of the synaptic vesicle cycle. For example, through Munc13, the CAZ is involved in the 
priming of synaptic vesicles and, through Piccolo, it might play a role in coordinating 
exocytic and endocytic steps (Fejtova and Gundelfinger, 2006). RIMs are central elements 
of active zone  that interact with most other active zone proteins. Functionally, RIM 
proteins perform at least two essential functions. First, RIM proteins regulate the priming 
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activity of Munc13 (Deng et al. 2011). Second, RIM proteins tether Ca
2+
-channels to the 
active zone, in fact only very recently the molecular mechanism recruiting Ca
2+
-channels 
to active zones was shown to depend on RIM proteins (Kaeser et al. 2011) (Fig. 2).   
 
 
Figure 2. Molecular model of the active zone protein complex and its relation to the synaptic vesicle fusion 
machinery, Ca
2+
 channels, and synaptic cell-adhesion molecules (from Sudhof 2012).  
 
Synaptic transmission is initiated when an action potential triggers neurotransmitter release 
from a presynaptic nerve terminal (Katz, 1969). An action potential induces the opening of 
Ca
2+
 channels, and the resulting Ca
2+
 transient stimulates synaptic vesicle exocytosis.  
With a diameter of approximately 40 nm, SVs are small organelles, making them 
comparable in complexity to other supramolecular structures such as ribosomes, 
spliceosomes, or viruses.  
Synaptic vesicles contain two classes of obligatory components: transport proteins 
involved in neurotransmitter uptake and trafficking and proteins that participate in synaptic 
vesicle exo- endocytosis and recycling. Transport proteins are composed of a vacuolar-type 
proton pump (V-ATPase) that generates the electrochemical gradient, which fuels 
neurotransmitter uptake and neurotransmitter transporters that mediate the actual uptake. 
In 2006 Takamori proposed a model that integrates all quantitative data and includes 
structural models of abundant proteins (Fig. 3). Takamori et al. observed that a few 
proteins, essential for membrane traffic and neurotransmitter uptake, are very abundant in 
synaptic vesicles (synaptobrevin2/VAMP2 is present in 70 copies for vesicle, 
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synaptophysin1 in 30 copies per vesicle, synaptotagmin1 in 15 copies per vesicle); in 
contrast many proteins are present in only a few copies per vesicles (the proton pomp is the 
prominent example: only one to two copies for vesicle) (Takamori et al., 2006). 
 
  
Figure 3. The model is based on space-filling models of all macromolecules at near atomic resolution. (A) 
Outside view of a vesicle. (B) View of a vesicle sectioned in the middle (the dark-colored membrane 
components represent cholesterol) (from Takamori et al., 2006). 
 
Calculation of the relative occupancy of the vesicle membrane by lipids and protein 
transmembrane regions suggests that approximately 20% of the membrane is occupied by 
transmembrane regions. Given that each transmembrane region is presumably surrounded 
by a ring of fixed phospholipids, this finding implies that there is very little fluid 
phospholipid membrane present in synaptic vesicles. Thus, the membrane of the synaptic 
vesicles is more rigid than anticipated (Sudhof, 2006). 
 
THE SYNAPTIC VESICLE CYCLE 
Synaptic vesicles undergo a trafficking cycle in the nerve terminal that can be divided into 
sequential steps: first, neurotransmitters are actively transported into synaptic vesicles (step 
1), second, synaptic vesicles cluster in front of the active zone (step 2). Then synaptic 
vesicles dock at the active zone (step 3), where the vesicles are primed (step 4) to convert 
them into a state of competence for Ca
2+
-triggered fusion-pore opening (step 5) (Fig. 4). 
After fusion-pore opening, synaptic vesicles endocytose and recycle probably by three 
alternative pathways, which are thought to coexist: (a) vesicles are reacidified and refilled 
with neurotransmitters without undocking, thus remaining in the readily releasable pool 
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(step 6, called “kiss-and-stay”); (b) vesicles undock and recycle locally (step 7, called 
“kiss-and-run”) to reacidify and refill with neurotransmitters (back to steps 1 and 2); or (c) 
vesicles endocytose via clathrin-coated pits (step 8) and reacidify and refill with 
neurotransmitters either directly or after passing through an endosomal intermediate (step 
9). Most successive steps occur without much vesicle movement except for docking (step 
3) and recycling (steps 7–9). 
 
 
Figure 4. The synaptic vesicle cycle. Synaptic vesicles are filled with neurotransmitters by active transport 
(step 1) and form the vesicle cluster that may represent the reserve pool (step 2). Filled vesicles dock at the 
active zone (step 3), where they undergo a priming reaction (step 4) that makes them competent for Ca2
+ 
triggered fusion-pore opening (step5). After fusion-pore opening, synaptic vesicles undergo endocytosis and 
recycle via several routes: local reuse (step 6), fast recycling without an endosomal intermediate (step 7), or 
clathrin-mediated endocytosis (step 8) with recycling via endosomes (step 9). Steps in exocytosis are 
indicated by red arrows and steps in endocytosis and recycling by yellow arrows (from Sudhof, 2004). 
 
Synaptic vesicle endocytosis is a calcium-dependent process; its speed is therefore 
increased in an activity-dependent manner, so the vesicle pool is replenished faster. The 
endocytotic pathway called kiss-and-run predicts that synaptic vesicles maintain their 
molecular identity, remain on the same spot at the active zone, are rapidly reloaded with 
neurotransmitter, and are ready for the arrival of a new action potential for a new round of 
exocytosis.  
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Synaptic vesicles, before the release of their contents, dock at the pre-synaptic membrane 
of active zones or ribbon synapses and undergo a priming reaction that prepares them for 
exocytosis/neurosecretion. Vesicle fusion and pore formation are facilitated by high-
affinity interaction of a group of highly-conserved proteins, collectively called SNAREs 
(soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors). SNARE 
proteins associated with the vesicles are termed vesicle-SNAREs (v-SNAREs) and those 
on the presynaptic plasma membrane are called target-SNAREs (t-SNAREs). Vesicles are 
released synchronously as well as asynchronously, and their mode of release is determined 
by proteins such as synaptotagmins and complexins that interact and regulate 
conformational changes within the SNARE proteins (Krishnakumar et al., 2011). The first 
step in vesicle fusion is “tethering,” where the vesicles are brought to the active zone to be 
attached to protein complexes at the presynaptic membrane (Whyte and Munro, 2002), 
facilitating contact between v-SNARE and t-SNARE proteins. At the presynaptic 
membrane of neurons, syntaxin 1A is attached to Munc-18, forming a closed structure 
(Smyth et al., 2010). The tethering process is thought to detach this complex and open 
syntaxin 1A for SNARE interaction. Munc-18 activates exocytosis/neurosecretion 
(Gracheva et al., 2010) with its dissociation from the syntaxin 1A closed form, freeing the 
SNARE motif for complex formation (Dulubova et al., 1999 and Shi et al., 2011). 
However, there is evidence for a continued association of Munc-18 with the amino 
terminus of syntaxin 1A in the assembled SNARE complex. Munc-18 may also be 
involved in chaperoning syntaxin 1A to the membrane (Shi et al., 2011). The tethering step 
is followed by docking of vesicles, where SNARE proteins come in contact with each 
other via the SNARE motifs in a calcium-independent manner. Docking is followed by 
vesicle priming, where the SNARE proteins form a stable complex via their SNARE 
motifs, rendering the vesicles competent for fusion (Fig. 5).  
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Figure 5. Steps in vesicle fusion include vesicle tethering, docking, priming and finally, fusion. These events 
are driven by high-affinity interaction between v-SNARE and t-SNARE proteins, regulated by calcium and 
calcium-binding proteins through their interaction with the SNARE complexes (Ramakrishnan et al., 2012).  
 
The function of SNARE-proteins in fusion has been referred to as the “SNARE 
hypothesis”, it describes a mechanistic model of membrane fusion based on the 
characteristics of plasma membranes and exocytosis/neurosecretion. It is assumed that the 
SNARE proteins present in the acceptor (plasma membrane) and donor (vesicle) 
membranes mediate the spatial specificity of the interaction between the vesicle and 
presynaptic membrane preceding fusion (Sollner et al., 1993). SNARE-proteins contain a 
characteristic sequence, referred to as the SNARE motif (Fig. 6), that comprises 60–70 
residues composed of eight heptad repeats. Most SNARE proteins contain one SNARE 
motif, whereas SNAP-25 and its homologs (SNAP-23, -29, and -47) include two SNARE 
motifs.  
 
Figure 6. Schematic diagram of the domain structures of syntaxin, SNAP-25, and synaptobrevin/VAMP 
(Habc, Habc-domain; TM, transmembrane region) (from Sudhof and Rizo 2011). 
 
 
 
The four SNARE motifs of synaptic SNARE proteins assemble into the four-helix coiled 
coil structure of the SNARE complex (Fig. 7) (Poirier et al. 1998; Sutton et al. 1998), with 
one SNARE motif each from synaptobrevin and syntaxin-1, and two SNARE motifs from 
SNAP-25. 
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Figure 7. Synaptobrevin2 and syntaxin1A form continuous helices. (a) Ribbon plot of the synaptic SNARE 
complex including linkers and TMRs (colour coding as in Fig. 7; Sx1A, syntaxin1A; Syb2, synaptobrevin2; 
SN1, SN2, SNAP-25; TMR, trans-membrane region). (b) Surface plot showing the electrostatic potential of 
the synaptic SNARE complex (blue, positive charge; red, negative charge) (from Stein et al., 2009)  
 
The SNARE cycle starts with the amino- to carboxy-terminal zippering of trans-SNARE 
complexes that bridge the gap between the membranes destined to fuse. Full zippering of 
trans-SNARE complexes likely produces fusion-pore opening, although it is possible that 
the full zippering only stresses the membranes and that fusion-pore opening occurs 
subsequently mediated by the SM protein. After fusion pore opening, the two membranes 
completely merge, and trans-SNARE complexes are converted into cis-SNARE complexes 
(i.e., SNARE complexes are on a single membrane), which are dissociated into monomers 
by NSF and SNAPs (Fig. 8). 
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Figure 8. The SNARE/SM protein cycle. During priming, SNARE proteins partially zipper up into trans-
complexes, and the SM protein associates with the trans-complexes by binding to the syntaxin amino 
terminus (left diagram). Full SNARE-complex assembly then pulls the membranes apart, opening the fusion 
pore (bottom diagram), which expands such that the vesicle membrane collapses into the target membrane, 
and the trans-SNARE complexes are converted into cis-SNARE complexes (right diagram). Afterward, cis-
SNARE complexes are dissociated by the ATPase NSF acting in conjunction with its adaptors a/b/g-SNAPs, 
and vesicles recycle to start another round of the cycle (from Sudhof and Rizo 2011). 
 
 
Several synaptic protein may regulate the assembly of SNARE complexes. Members of the 
mammalian Munc13 protein family have been found to be absolutely required for the 
priming process (Aravamudan et al., 1999; Augustin et al., 1999; Richmond et al., 1999; 
Brose et al., 2000). Its function is tightly regulated by Ca
2+
 (via the C2B-domain, 
diacylglycerol synthesis, and calmodulin) and RIM. In priming, Munc13 probably acts via 
a direct or indirect interaction of the MUN-domain with SNARE and/or SM proteins (Ma 
et al. 2011).   
Complexins are small cytoplasmic proteins that bind via a central helix to a groove on the 
surface of the SNARE complex, which is formed by the helices of syntaxin and 
synaptobrevin. These act to modulate SNARE-mediated exocytosis by their calcium-
dependent interaction with the assembled SNARE core complex (SNAREpin), thus 
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“clamping” the SNARE and temporarily arresting exocytosis (Bracher et al., 2002, Chen et 
al., 2002 and Giraudo et al., 2006). Clamping of SNAREpins by complexins 1 and 2 is 
necessary for synchronous exocytosis. Complexins also potentiate fusogenicity of vesicles 
by interacting with SNAREs through their N-termini (Xue et al., 2010). Further, it has been 
suggested that the complexin-SNARE interaction regulates the force that trans-SNARE 
complexes apply to the fusing membranes (Maximov et al., 2009).   
Tomosyn, snapin and Munc18 are presynaptic proteins that can regulate the assembly of 
SNARE complexes. Tomosyn binds to both syntaxin and SNAP-25 to form a similar 
structure to the SNARE complex (Hatsuzawa et al., 2003; Pobbati et al., 2004). Both the 
SNARE complex and the trimeric tomosyn-syntaxin-SNAP-25 complex form at a similar 
rate, and synaptobrevin is unable to displace tomosyn from the existing complex, 
suggesting that the tomosyn-syntaxin-SNAP-25 complex represents an end product. As a 
consequence of preventing SNARE complex formation, tomosyn inhibits secretion in 
various neuroendocrine cells (Hatsuzawa et al., 2003; Yizhar et al., 2004; Zhang et al., 
2006). Interestingly, the trimeric complex containing tomosyn cannot bind complexin 
(Pobbati et al., 2004) suggesting that, in a functional environment such as the presynapse, 
the formation of the SNARE complex containing synaptobrevin might still be favoured. 
Snapin is another modulatory protein of SNARE complexes which binds to SNAP-25 in 
vitro (Ilardi et al., 1999) and it may stabilize the interaction between synaptotagmin and the 
SNARE complex (Tian et al., 2005).  
The SM protein Munc18-1 is as essential for exocytosis of synaptic and secretory vesicles 
as the SNARE proteins. This protein forces syntaxin to adopt a closed conformation that 
prevents its participation in the SNARE complex, thus “negatively” regulating SNARE 
complex formation. Naturally, Munc18-1 has been assumed to dissociate from syntaxin 
before SNARE complex formation can occur. This hypothesis is supported by biochemical 
data showing that the priming factor Munc13 displaces Munc18-1 from syntaxin in vitro 
(Sassa et al., 1999). However, one can equally well assume that the Munc18-1/syntaxin 
interaction is only weakened, and still persists, during SNARE complex assembly. A 
second model for Munc18-1 action is based on the observation that SM proteins, including 
Munc18-1, protect their syntaxin partner from degradation (Bryant and James, 2001; Rowe 
et al., 2001), although 50-70% syntaxin persist in the absence of Munc18-1 (Voets et al., 
2001; Weimer et al., 2003; Toonen et al., 2005). In a third model, synaptobrevin diplaces 
from membrane sheets by binding to the other SNARE proteins (Zilly et al., 2006), and 
Munc18-1 was found to accelerate vesicle fusion in vitro (Shen et al., 2007). The 
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controversy about Munc18-1 role in vesicle fusion machinery has been partially solved by 
Sorensen and colleagues (Gulyás-Kovács et al., 2007), who demonstrated in chromaffin 
cells that Munc18-1 participates in two different steps of exocytosis: during the docking 
phase, it binds to the closed conformation of syntaxin1 thus promoting vesicle docking and 
excluding a “negative” role in the fusion machinery; after vesicle docking, Munc18-1 
appears to engage in a distinct interaction with the exocytotic machinery in a different 
conformation, thus promoting vesicle priming (Fig. 9) (Gulyás-Kovács et al., 2007). A 
kinetic role in which SM proteins cooperate with SNAREs by helping them assemble into 
productive topological arrangements at the interface of two membranes (such as ring-like 
arrangements that could facilitate the opening of fusion pores), possibly by restricting the 
diffusion of SNAREs into the space between fusing membranes, has also been proposed 
(Rizo et al., 2006; Sudhof and Rothman, 2009).  
Another class of proteins that may regulate SNARE function at the synapse are 
synaptophysins, abundant synaptic vesicle proteins that bind directly to synaptobrevin 
(Johnston and Sudhof, 1990; Calakos and Scheller, 1994; Edelmann et al., 1995; 
Washbourne et al., 1995). Synaptobrevin cannot simultaneously bind to synaptophysins 
and participate in the SNARE complex, which suggests that binding of synaptobrevin to 
synaptophysin restricts the availability of synaptobrevin for fusion (Edelmann et al., 1995, 
Becher et al., 1999). Consistent with this hypothesis, the synaptobrevin/synaptophysin 
complex is upregulated during development (Becher et al., 1999) and chronic blockade of 
glutamate receptors, which caused an increase in neurotransmitter release, decreases the 
formation of synaptobrevin/synaptophysin complex (Bacci et al., 2001). 
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Figure 9. Priming I involves arrest of a partially zippered SNARE complex, here shown with bound 
Munc18, Munc13 and synaptotagmin. Calcium influx triggers binding of synaptotagmin to the SNARE 
complex and to the plasma membrane (involving PI(4,5)P2, not shown here), associated with displacement of 
complexin and (possibly) Munc18 and/or Munc13. Priming II involves arrest after positioning of the vesicle 
with the aid of active zone components and (possibly) contact of synaptotagmin with PI(4,5)P2 in the plasma 
membrane, but no contact between the SNAREs. Ca
2+
-triggering pulls the vesicle closer via synaptotagmin-
mediated cross-linking, resulting in SNARE assembly, associated with full opening of syntaxin and 
displacement of Munc18, and binding of complexin (from Jahn and Fausshauer 2012).  
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THE RAB3 CYCLE  
Rabs constitute the largest family of small Ras-like GTPases with 11 identified in yeast and 
more than 60 members in humans and regulate intracellular transport. Synaptic vesicles 
contain members of at least three families of Rab proteins: Rab3 (Rab3A, 3B, 3C, and 3D) 
(Schluter et al., 2002), Rab5 (Fischer von Mollard et al., 1994), and Rab11 (Khvotchev et 
al., 2003). Of these, Rab3 proteins are the most abundant; Rab3A alone accounts for ~25% 
of the total Rab GTP binding in brain (Geppert et al., 1994). Rab3 molecules are attached to 
the membrane by a post-translational modification of the c-terminal residues consisting of 
two geranylgeranyl chain, which confer the properties of an intrinsic membrane protein of 
synaptic vesicles (Johnston et al., 1991). Rab3 undergoes a cycle of synaptic vesicle binding 
and dissociation in parallel with synaptic vesicle exo- and endocytosis (Fischer von Mollard 
et al., 1991). During or after synaptic vesicle fusion, GTP on Rab3 is hydrolyzed to GDP 
and Rab is then removed from the membrane by guanine nucleotide dissociation inhibitor 
(GDI) in preparation for the next cycle (Araki et al., 1990). The insertion of the Rab into the 
target membrane is mediated by a GDI dissociation factor (GDF) that releases the Rab from 
GDI. Rab3 dissociation from vesicles depends on Ca
2+
-triggered exocytosis of synaptic 
vesicles (Fischer von Mollard et al., 1991), which suggests that the Rab3 cycle ensures 
directional interactions of Rab3 with effector proteins during exocytosis (Fig. 10). 
 
 
 
 
Figure 10. Model of RAB GTPase cycle. (A) RAB proteins cycle between the inactive (GDP-bound, green) 
and active (GTP-bound, magenta) forms. Two major classes of proteins are involved in this regulation. The 
RAB guanine nucleotide exchange factor (GEF, purple) exchanges bound GDP for GTP, and the RAB 
GTPase activating protein (GAP, brown) accelerates GTP hydrolysis on the active RAB protein. GTP, red; 
GDP, yellow. (B) RAB proteins cycle between the cytosol and various membranes (from Saito and Ueda 
2009).   
A B 
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FUSION PORE 
Porosomes have been demonstrated to be secretory portals at the plasma membrane in cells 
(Jena, 2005 and 2007). Porosomes are supramolecular lipoprotein structures at the cell 
plasma membrane, where membrane-bound secretory vesicles transiently dock and fuse to 
release inravesicular contents to the outside during cell secretion (Lee et al., 2012). 
Lipids of the vesicles diffuse in the plasma membrane, whereas proteins remain in the 
vesicle (Taraska et al., 2003; Perrais et al., 2004; Fulop et al., 2005). Various lipids and 
proteins in the vesicle and plasma membranes have been revealed to be actively involved 
in the formation, stabilization, and pre-/post-fusional regulation of fusion pores. It has been 
suggested that a circular arrangement of five to eight syntaxin transmembrane segments 
could form proteinaceous fusion pores and that the lipid molecules might intercalate 
between them to complete the structure (Han et al. 2004). Fusion pore formation is thought 
to be associated with conformational change in the soluble N-ethylmaleimide-sensitive 
factor activating protein receptor (SNARE) complex that is formed between the vesicle and 
the plasma membranes (Michael et al. 2006; Schweizer and Ryan 2006). 
The membrane spanning C -terminus of syntaxin has been shown to line the fusion pore 
(Han et al., 2004), since a change in the residues of syntaxin C-terminus facing the pore 
lumen disturbs catecholamine release. Synaptobrevin seems to regulate the timing and the 
dilation of the fusion pore. Indeed, in chromaffin cells deprived of synaptobrevin, 
exocytosis is supported by cellubrevin, a close homolog of synaptobrevin2, albeit with 
slower kinetics and with a prolonged foot signal (Borisovska et al., 2005). Finally, as 
expected from a protein without a transmembrane domain, the third SNARE, SNAP-25, is 
probably not involved in fusion pore formation or dilation, as no mutant studied so far has 
been shown to have any effect on these parameters (Becherer and Rettig, 2006). 
Nevertheless SNAP-25, interacting with synaptotagmin, can control fusion pore dynamics 
during the final steps of exocytosis (Bai et al., 2004). An important functional role of 
phosphatidylserine (PS) in Ca
2+
-triggered exocytosis has been suggested. Increase in PS 
content in PC12 cells has two distinct and opposing effects on the kinetic of exocytosis, 
enhancing an early step leading to fusion pore opening, and slowing a later step when 
fusion pores dilate (Zhang et al., 2009).  
Synaptotagmin 1 is thought to trigger exocytosis through its Ca
2+
-dependent interactions 
with PS-containing liposomes and SNARE proteins (Chapman et al., 2002). Its isoforms 
and its mutants can influence the stability of initial fusion pores (Bai et al., 2004; Wang et 
al., 2001; Zhang et al., 2010), suggesting that it may interact with this fusion intermediate.  
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THE SYNAPTOTAGMIN 
Synaptotagmins are synaptic and secretory vesicle proteins that contain a single N-terminal 
transmembrane region, and two C-terminal Ca
2+
-binding C2-domains (Perin et al. 1990). 
There were identified 16 mammalian synaptotagmin isoforms, 8 of which bind Ca
2+
 with 
distinct apparent Ca
2+
-affinities (Syt1-3, Syt5-7, Syt9, and Syt10) (Li et al.1995; Bhalla et 
al. 2005). Evidence accumulated over the past  years demonstrates that the synaptotagmins 
are the major Ca
2+
 sensor in synchronous Ca
2+
-dependent synaptic transmission (Brose et 
al., 1992; Davletov and Sudhof, 1993; Geppert et al.,  1994; Sutton et al., 1995; Sudhof 
and Rizo, 1996; Desai et al., 2000; Fernandez-Chacon et al., 2001; Littleton et al., 2001). 
Synaptotagmins 1 and 2 are abundant synaptic vesicle proteins that are differentially 
expressed (Geppert et al., 1991; Ullrich et al., 1994). Synaptotagmins are anchored to the 
vesicle through an N-terminal transmembrane domain and possess tandem C2 domains 
(C2A and C2B) of ~135 amino acids in their cytoplasmic domains. These C2 domains bind 
to lipids containing phosphatidyl serine and phosphatidyl choline, and, with micromolar 
affinity, to Ca
2+
 (Bai and Chapman, 2004): the C2A domain of synaptotagmin 1 binds 
three Ca
2+
 ions (Ubach et al., 1998), and the C2B domain two Ca
2+
 ions (Fernandez-
Chacon et al., 2001). The binding of synaptotagmin with phospholipids is essential for 
achieving a physiologically apparent Ca
2+
 affinity. Blocking Ca
2+
-binding to the C2B-
domain blocks synchronous exocytosis (Mackler et al. 2002), whereas blocking Ca
2+
-
binding to the C2A-domain decreases exocytosis ~40%, and additionally decreases the 
apparent Ca
2+
-cooperativity of exocytosis ~40% (Shin et al.2009). Thus, the two C2-
domains of synaptotagmins thus are not equivalent, but they cooperate with each other, 
with the C2B-domain playing the leading part. 
There is clear evidence for a role of synaptotagmin in the docking, mediated by its 
interaction with SNAP-25 (Chieregatti et al., 2002), and in the fusion process (Wang et al., 
2001; 2003; 2006). Synaptotagmins have been long considered Ca
2+
 sensors for evoked but 
not for spontaneous transmission, given that deletions of Syt1 and of Syt2 increase 
spontaneous release (Littelton et al., 1994; Maximov et al., 2005; Pang et al., 2006). 
However, it has been recently demonstrated that  Syt1 deletion strongly decreased the fast 
component of AP-evoked release in synapses of neuron cultures from Syt1 knockout (KO) 
mice. On the other hand, asynchronous release was increased at both types of synapses 
(Geppert et al., 1994; Nishiki et al., 2004; Maximov et al., 2005; Yoshihara et al., 2002). 
Similarly, spontaneous release was increased after Syt1 genetic deletion in cultured 
neurons from Syt1 KO mice, leading to the idea that Syt1 has a second function in 
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suppressing spontaneous release („release clamping‟) in addition to its primary role as a 
Ca
2+
 sensor. By interacting with the SM protein Munc18-1, synaptotagmin also has a role 
in positioning vesicles at the synapse during the docking phasem; there were describe two 
alternative models. 
Finally, a role of Syt in membrane bending has been recently demonstrated by utilizing 
membranes with different degrees of curvature (Hui et al., 2009); interaction of Syt with 
lipid bilayers serves to drive localized invagination of the target membrane to facilitate 
fusion (Monck and Fernandez, 1994) and constitutes a critical step in Ca
2+
 regulated fusion 
(Hui et al., 2009). 
 
 
THE SNARE PROTEIN SNAP-25 
SNAP-25 is a hydrophilic protein of 206 amino acids was originally identified as a cDNA 
corresponding to an mRNA abundantly expressed in mouse brain but not in non-neuronal 
tissue (Oyler et al., 1989). It has been demonstrated that SNAP-25 is widely but differently 
distributed both in the nervous system as well as in neuroendocrine and endocrine cells 
(Jacobsson et al., 1994, 1996, 1999; Bark et al., 1995; Gonelle-Gispert et al., 1999) and 
with an onset of gene expression that correlates to neuronal maturation (Catsicas et al., 
1991). SNAP-25 associates with membranes through palmitoyl residues that are thioester-
linked to four closely spaced cysteine residues at the centre of the protein. The amino- and 
carboxy-terminal domains are highly conserved and are predicted to form intermolecular 
coiled coils. The Snap-25 gene is a single gene spanning more than 80 kb of genomic DNA 
and the polypeptide is encoded for by eight different exons spaced by quite large intron 
sequences (Bark, 1993). SNAP-25 exists in two isoforms, SNAP-25a and SNAP-25b, 
which arise from alternate splicing of exon 5, and are differentially expressed throughout 
the nervous system, both encoding for 39 amino acids (Bark and Wilson, 1994). SNAP-25a 
and SNAP-25b differ by only nine amino acids and include the region in the SNAP-25 
protein that spans the last part of the N-terminal SNARE motif and the first part of the 
linker that separates the N- and C-terminal α-helices. Thus, the amino acid differences 
participating in forming the four α-helix coil–coil structure in the SNARE complex could 
possibly interfere with SNARE complex stability or ability to interact with accessory 
proteins. In addition, differences in the  linker region distort the cystein quartet, and 
although all four cysteines are retained, they appear in a different organization and 
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sequence context (Bark, 1993; Bark and Wilson, 1994). Studies of gene expression of these 
two alternative SNAP-25 variants in mouse brain have demonstrated that the two mRNAs 
are differently expressed during development and their neuroanatomical distributions are 
individual and distinct. In rat brain, SNAP-25b protein expression increased dramatically 
during post-natal development and was similar in hippocampus, cerebellum and cortex, 
implying that changes in expression of this isoform are largely occurring at a global level. 
On the other hand SNAP-25a is mostly expressed at early stages of brain development 
(Oyler et al., 1991; Bark et al., 1995; Boschert et al., 1996), whereas during the post-natal 
period the increase in its expression was more modest and variable (Prescott et al., 2011). 
The increase in SNAP-25b expression coincides in particular with the specific elevation of 
the mRNA splice variant b (Bark et al., 1995; Boschert et al., 1996) and with the 
concomitant shift of the protein from cell bodies to cell processes and presynaptic 
terminals (Oyler et al., 1991; Bark et al., 1995; reviewed in Hepp and Langley, 2001). 
Examination of  neuroexocytosis from chromaffin cells of Snap-25 null mice clarified how 
alternative splicing of SNAP-25 may affect Ca
2+
 triggered exocytosis (Sorensen et al., 
2003). Chromaffin cells contain two pools of releasable vesicles: the readily releasable 
pool (RRP) and the slowly releasable pool (SRP) (Voets et al., 1999). In this model, 
SNAP-25b-driven secretion is characterized by a more than 2-fold larger size of the SRP 
and the RRP as compared to SNAP-25a, suggesting that the progressive increase in SNAP-
25b mRNA relative to SNAP-25a during the first week of postnatal brain development 
(Bark et al., 1995) could be required for increasing pools of primed vesicles to meet the 
needs of synaptic maturation (Sorensen et al., 2003). 
Genetic experimental approaches have demonstrated that SNAP-25 is not required for 
stimulus-independent neurotransmitter release, but is essential for evoked synaptic 
transmission (Washbourne et al., 2002). Genetic ablation of the t-SNARE SNAP-25 
abolished completely evoked release, without affecting spontaneous release. Moreover, 
Snap-25 null-mutant neurons showed higher frequencies in spontaneous events as 
compared to wild-type neurons, suggesting a dual role in membrane fusion: SNAP-25 can 
act as positive regulator in action potential-dependent release, and simultaneously it can act 
as negative regulator to inhibit spontaneous events (Washbourne et al., 2002). Nevertheless 
very recently, Bronk et al. (2007) analyzed neurotransmission in hippocampal cultures 
from Snap-25-deficient mice. They confirmed the block of evoked glutamatergic 
transmission but they observed the persistence of  spontaneous neurotransmission, 
although at a much lower frequency than in heterozygous cultures.   
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DIFFERENT ISOFORMS OF SNAP-25 
Multiple isoforms and homologous proteins, originated by differential splicing of single 
genes or codified by different genes of the same family, respectively, have been described 
for VAMP, syntaxin and SNAP-25. The homologous forms of SNAP-25 comprise SNAP-
23, SNAP-29 and SNAP-47 proteins (Fig. 11). 
SNAP-23 shows 58 % identity at the aminoacidic level with SNAP-25 and it is 
ubiquitously expressed. Similarly to SNAP-25, SNAP-23  is localized to the plasma 
membrane (Wang et al. 1997), and assumes the essential functions in a variety of exocytic 
reactions in non-neuronal cells, nevertheless it has been detected in cortical neurons and in 
purified synaptic vesicles (Bragina et al. 2007; Takamori et al. 2006). SNAP-23 is 
proposed to bind another synaptotagmin isoform, syt7, which binds calcium with ~10-fold 
higher affinity (Shin and Sugita et al. 2002) and allows SNAP-23 to mediate granule 
docking and fusion at resting calcium levels (Chieregatti  et al. 2004). Thus, SNAP-23 can 
support synaptic vesicle fusion in the absence of SNAP-25 and may function in a SNARE 
complex driving asynchronous and/or spontaneous neurotransmitter release.   
SNAP-29 displays 39% similarity relative to SNAP-25; it has been proposed to be a 
ubiquitous cytoplasmic SNARE protein involved in general membrane trafficking 
(Hohenstein, 2001). Recent studies suggested that SNAP-29 is present at synapses and can 
act as a negative modulator for neurotransmitter release, probably by slowing recycling of 
the SNARE-based fusion machinery and synaptic vesicle turnover (Pan, 2005). 
SNAP-47 revealed ubiquitous tissue distribution, with particularly high levels in the brain. 
In neurons, SNAP-47 shows a widespread distribution on intracellular membranes and is 
also enriched in synaptic vesicle fractions. In vitro, SNAP-47 can functionally substitute 
for SNAP-25 in SNARE complex formation with the neuronal SNAREs syntaxin 1a and 
synaptobrevin 2, and it also substituted for SNAP-25 in proteoliposome fusion. However, 
neither complex assembly nor fusion was as efficient as with SNAP-25 (Holt, 2006).  
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Figure 11. Schematic view of the domain structure of SNAP-25 isoforms. All SNAP-25 homologues contain 
tandem SNARE motifs (boxed). Note that SNAP-47 has an extended N-terminal domain and linker region 
compared with other Q-SNAREs. Sequences are illustrated at scale. Note the palmitoylation sites in the 
linker region indicated on SNAP-23 and SNAP-25. 
 
SNAP-25 EXPRESSION IN EXCITATORY AND INHIBITORY NEURONS 
Normal brain function relies on the fine balance of activity between the two most diffuse 
fast synapse populations in the CNS, the inhibitory GABAergic and the excitatory 
glutamatergic terminals. In the past years, evidences have accumulated demonstrating that 
GABAergic and glutamatergic neurons express different molecular components involved 
in neuronal development, intracellular signalling and pre-postsynaptic functions. In 2004, 
in a paper of our group, initial evidence emerged demonstrating that mature GABAergic 
inhibitory synapses express much lower levels of SNAP-25 than excitatory glutamatergic 
synapses (Verderio et al., 2004).  
In 1989 Oyler and colleagues described the isolation and characterization of cDNA clones 
encoding a novel 25-kDa synaptosomal protein, SNAP- 25, showing that the proteinwas 
heterogeneously expressed in distinct populations of neurons (Oyler et al., 1989). This 
report was subsequently followed by other studies indicating that SNAP-25 is expressed in 
specific subtypes of conventional synapses, but not ribbon synapses (Catsicas et al., 1992), 
that variable SNAP-25 expression occurs in autonomic vasoconstrictor and vasodilator 
neurons in central and peripheral inputs to sympathetic neurons (Morris et al., 2000; 
Gibbins et al., 2003), and that heterogeneous levels of the protein are present in VAChT-
containing varicosities of the ventral horn of the spinal cord (Hellstrom et al., 1999). Duc 
and Catsicas (1995) in particular reported that only a subset of central nervous system 
synapses display SNAP-25 immunostaining at the electron microscopy level.  
In 2004, our group reported the lack of SNAP-25 immunoreactivity at inhibitory synapses 
of mature rat hippocampal cultures and adult rat hippocampus (Verderio et al., 2004). To 
determine the expression of SNARE proteins in excitatory and inhibitory hippocampal 
neurons in primary culture we used immunocytochemistry. Staining with various 
antibodies directed against SNAP-25 and recognizing both the a and b isoforms (Bark and 
Wilson, 1994) revealed the specific presence of the protein in processes of glutamatergic 
neurons. In contrast, processes of GABAergic neurons, identified by their labelling for the 
neurotrasmitter, or for the GABA vesicular transporter vGAT, or for the GABA-
22 
 
synthesizing enzyme glutamic acid decarbosilase (GAD), lacked the immunoreactivity for 
SNAP-25 (Fig. 12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. A triple immofluorescence labeling of hippocampal neurons for SNAP-25 (red), VGlut (green), 
and glutamic acid decarboxylase (GAD; blue). Arrow indicates a GAD-positive GABAergic neuron 
expressing lower levels of SNAP-25 (from Condliffe et al. 2010). 
 
This finding was validated in slices from adult rat hippocampus, where SNAP-25, was 
found to be largely excluded from inhibitory terminals in CA1 region. One year later, 
Frassoni et al. (2005) investigated whether distinct interneuron subpopulations may differ 
for their content in SNAP-25, and this was evaluated in sections from adult rat 
hippocampus. One of the most useful characterizations of interneuron subtypes has been 
based on the presence of calcium-binding proteins such as parvalbumin (PV) and calretinin 
(CR). It was found that SNAP-25 immunoreactivity was undetectable in the large majority 
of PV-positive synapses in the stratum pyramidale of rat hippocampus while the same 
terminals were instead immunopositive for the plasma membrane SNARE syntaxin-1; 
SNAP-25 was also undetectable in CR-immunoreactive terminals. The lack of SNAP-25 
immunoreactivity was also demonstrated in axon terminals of CCKpositive cells and in 
SOM-positive axon terminals (Frassoni et al., 2005). 
This observation was subsequently extended to adult mouse hippocampus (Frassoni et al., 
2005). Notably, a partial colocalization between SNAP-25 and GAD immunoreactivities at 
early postnatal stages (P0–P5) of development, when GAD staining is concentrated 
primarily in fine processes with periodic varicosities within the developing stratum 
radiatum (Dupuy and Houser, 1996). this colocalization became undetectable in the adult, 
suggesting a developmentally regulated down-regulation of the protein. The expression of 
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SNAP-25 was also examined in cultures of  rat hippocampal neurons at different stages of 
development: colocalization between SNAP-25 and GABAergic markers was present in 
developing neurons at early stages in culture indicating a developmentally-regulated 
disappearance of SNAP-25 immunoreactivity during interneuron differentiation (Frassoni 
et al., 2005) (Fig. 13).  
 
 
 
Figure 13. SNAP-25 immunoreactivity in rat cultured neurons at different developmental stages. (A) 2 DIV 
neurons double stained for vGAT and SNAP-25. Note that both the glutamatergic and the GABAergic 
neurons express detectable levels of SNAP-25. (B) Triple labeling of a 6 DIV culture for GABA (green), 
GAD (human serum, blue) and SNAP-25 (red). Note that, differently from the glutamatergic neuron, 
processes belonging to a multipolar GABAergic neuron, are virtually devoid of SNAP-25 immunoreactivity. 
SNAP-25 staining is instead detectable in the Golgi area and at the growth cone. (C) Triple labeling of a 15 
DIV culture, established from E18 rat hippocampi and maintained in the presence of an astrocyte feeding 
layer, for SNAP-25 (red), syntaxin (green) and GAD (human serum, blue). Note that the GAD-positive 
neuron does not express detectable levels of SNAP-25, while it is immunopositive for syntaxin. SNAP-25 
immunoreactivity appears to be excluded from GAD-positive presynaptic boutons (see red and blue merged 
image). Scale bars=18 µm, A; 12 µm, B; 10 µm, C. (from Frassoni et al., 2005). 
 
Bragina and colleagues (2007) confirmed the absence of  SNAP-25 immunoreactivity in 
adult GABAergic synapses in the cerebral cortex, also Garbelli and colleagues (Garbelli et 
al., 2008), who combined pre-embedding immunolabeling for SNAP-25 with post-
embedding immunogold localization of the neurotransmitter GABA, and Mandolesi and 
colleagues (Mandolesi et al., 2009), who did not detect SNAP-25 labeling in GABAergic 
terminals of both the molecular and granular layers of the cerebellum. Moreover, poor 
expression of SNAP-25 was observed in vGlut2 positive glutamatergic cerebellar neurons, 
A 
C 
B 
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while high levels of the protein were detected in vGlut1 positive cells, and a correlation 
between SNAP-25 expression and the release probability has been hypothesised 
(Mandolesi et al., 2009). On the contrary, Tafoya and colleagues (Tafoya et al., 2006) 
reported the presence of SNAP-25 immunoreactivity in developing cultured neurons from 
mouse and also showed the presence of high SNAP-25 levels at perisomatic basket cell 
terminals on CA1 pyramidal cells of the adult mouse hippocampus. The discrepancy 
between these results  have not been clarified and have been attributed to either 
methodological differences (Bragina et al., 2007) or to alterations in tissue preservation 
(Garbelli et al., 2008).  
 
Several studies were performed to understand whether GABAergic synaptic transmission 
is functional in the absence of SNAP-25 protein. These studies (Tafoya et al., 2006; Bronk 
et al., 2007; Delgado-Martinez et al., 2007) were carried out in brain slices or primary 
cultures from Snap-25 deficient fetal mice and provided essentially identical conclusions.  
Tafoya et al. (2006), performing whole-cell patch clamp recordings, showed the absence of 
detectable field stimulation-evoked GABAergic transmission in fetal brain slices from 
Snap-25 null mutants and a complete lack of stimulus-evoked synaptic vesicle exocytosis 
in Snap-25 null cultured interneurons. Bronk et al. (2007) demonstrated the block of 
evoked glutamatergic transmission in hippocampal cultures from Snap-25-deficient mice 
and the persistence of  spontaneous neurotransmission, albeit at a much lower frequency 
than in heterozygous cultures. They also examined evoked GABAergic transmission in the 
same cultures and they concluded that SNAP-25 plays an equally critical role in excitatory 
and inhibitory neurotransmission, at least throughout the synaptic maturation process in 
vitro (Bronk et al., 2007). Finally, Delgado-Martinez et al. (2007) found that inhibitory 
neurotransmission in Snap-25 null hippocampal or striatal cultures was rescued by 
lentiviral expression of SNAP-25a or SNAP-25b, with no significant differences in the 
IPSC amplitude, thus indicating that SNAP-25 supports inhibitory neurotransmission in 
developing cultures. 
The above results indicate that SNAP-25 is functionally required at most, if not all, 
GABAergic terminals at early developmental stages. This conclusion is in line with the 
pattern of SNAP-25 expression during neuronal differentiation (Frassoni et al., 2005). 
However, they do not provide conclusive evidence on the function of SNAP-25 as a 
SNARE protein in mature synapses. As the Snap-25 null mutants are not viable, the 
possibility indeed remains that SNAP-25 can play a role in GABAergic neurons 
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specifically at early developmental stages (Frassoni et al., 2005; Delgado-Martinez et al., 
2007). 
 
SNAP-25 AS A CELLULAR CALCIUM MODULATOR 
Evidence indicates an additional function of SNAP-25  in the modulation of various ion 
channels. In particular, the interaction of  SNAP-25 with different types of voltage-gated 
calcium channels (VGCCs), including N-type (Sheng et al., 1996), P/Q-type (Rettig et al., 
1996; Martin-Moutot et al., 1996) and L-type (Wiser et al., 1999) has been demonstrated in 
non-neuronal cells. The synaptic protein interaction (synprint) site of the voltage-gated 
Ca2+ channel (VGCC) α1 subunit can interact with proteins involved in exocytosis, and it 
is therefore thought to be essential for exocytosis of synaptic vesicles (Fig. 14). This 
interaction has been shown to alter channel function by inhibiting L-type channel currents 
(Ji et al., 2002), reducing N-type channel current (Wiser et al., 1996), or the activity of 
P/Q-type Ca
2+
 channels by negatively shifting the steady state voltage dependence of 
inactivation (Zhong et al., 2001).  
 
 
 
Figure 14. Transmembrane topology of the N-type calcium channel 1- subunit illustrating major protein 
interactions sites. The domain II – III linker region of vertebrate N-type channels contains a synaptic protein 
interaction site that interacts with syntaxin 1, synaptotagmin 1, and SNAP-25 (from Zamponi et al., 2003). 
 
Accordingly with these data, it has been previously reported that SNAP-25 can modulate 
intracellular calcium dynamics, and indeed differential SNAP-25 expression in 
hippocampal neurons is reflected by different calcium responsiveness; in particular, it was 
demonstrated that the exogenous expression of SNAP-25 significantly reduces calcium 
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responses to depolarizing stimuli in hippocampal neurons in cultures, while the silencing 
of the expression of the protein significantly increases neuronal calcium responsiveness 
(Verderio et al., 2004). Interestingly, hippocampal GABAergic neurons are characterized 
by a higher calcium responsiveness to depolarization compared to excitatory neurons and 
exogenous expression of SNAP-25 in interneurons significantly reduces calcium responses 
to depolarizing stimuli, which is consistent with the differential expression of the protein in 
excitatory and inhibitory neurons (Verderio et al., 2004). These data suggested that 
different levels of SNAP-25 expression in excitatory versus inhibitory neurons may 
profoundly modulate, in a concentration-dependent manner, neuronal responses to synaptic 
stimuli and that SNAP-25 is involved in the regulation of neuronal excitability. 
Pozzi et al. (2008) studied the SNAP-25 role as a modulator of calcium responsiveness in 
primary hippocampal cultures from Snap-25
+/+
 and Snap-25
+/- 
transgenic mice. The results 
revealed that cultures from Snap-25
+/- 
mutants display levels of SNAP-25 intermediate 
between Snap-25
+/- 
and wild-type neurons (Fig. 15), confirming previously reported data 
(Washbourne et al., 2002). Moreover, neuronal responsiveness to 30 mM KCl was 
inversely proportional to the amount of the expressed SNARE, with the highest and lowest 
calcium responsiveness being detectable in Snap-25
-/-
 and wild-type neurons, respectively 
(Fig. 15B) (Pozzi et al., 2008), which is in line with a concentration-dependent modulation 
of calcium dynamics (Verderio et al., 2004). 
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Figure 15. Calcium responsiveness to depolarization in wild-type, Snap-25
+/-
 and Snap-25
-/- 
neurons. (A) 
Immunofluorescence for SNAP-25 confirms the reduction and the abolishment of protein levels in 
heterozygous and knock-out neurons, respectively. (B) Calcium recordings from Snap-25
+/-
 and 
-/-
 cultures 
display a significant increase in the responses upon depolarization with 30 mM KCl both in 
+/-
 and in 
-/-
 
neurons. Noticeably, the increase in responses in inversely proportional to SNAP-25 expression levels 
(modified from Pozzi et al., 2008). 
 
 
The crucial region of SNAP-25 that controls neuronal calcium dynamics (residues 180–
197) contains a residue, ser187, which can undergo phosphorylation by PKC in an activity-
dependent manner. Pozzi et al. demonstrated that  negative control of VGCCs by SNAP-25 
requires phosphorylation of the protein on Ser187 residue, which is activity-dependent 
both in vitro and in vivo; therefore, this mechanism may mediate a negative feedback 
modulation of neuronal activity during sustained activation (Fig. 16). 
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Figure 16. SNAP-25 phosphorylation is modulated by network activity. (left) Western blot analysis of 
SNAP-25 phosphorylation in hippocampal cultures (12 DIV) in control conditions or after stimulation with 1 
uM PMA (PKC activator) for 30 min. (right) Time course of SNAP-25 phosphorylation in cultures exposed 
to 30 mM KCl for 5 min, immediately solubilized (KCl), or washed and solubilized after 30 or 60 min (from 
Pozzi et al., 2008). 
 
 
Given the differential expression of SNAP-25 in glutamatergic and GABAergic neurons, in 
a recent paper of our group (Condliffe et al., 2010) it was investigated the regulatory role 
of endogenous SNAP-25 on native voltage-gated calcium channels in cultured 
hippocampal neurons.  
Cultured glutamatergic and GABAergic neurons showed markedly different VGCC 
properties. Glutamatergic neurons had significantly lower VGCC current densities, 
enhanced inactivation rates and shifts in the voltage-dependence of activation and steady-
state voltage-dependent inactivation curves compared to GABAergic neurons (Fig. 17). 
Also, VGCC current inactivated at a faster rate in glutamatergic neurons and the voltage 
dependence of activation and inactivation of VGCC current varied between glutamatergic 
and GABAergic neurons. 
 
  
 
 
 
 
 
 
 
 
Figure 17. Reduced VGCC current density in glutamatergic compared to GABAergic neurons. 
 
 
These results suggested that diverse VGCC properties are the consequence of differential 
levels of endogenous SNAP-25 physically interacting with somatodentritic VGCCs to alter 
channel function. This conclusion is supported by the fact that silencing of endogenous 
SNAP-25 in glutamatergic neurons increased VGCC properties towards GABAergic levels 
while over-expressing SNAP-25 in GABAergic neurons reduced inward VGCC current 
and inactivation kinetics (Fig. 18).  
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Figure 18. Silencing of endogenous SNAP-25 in glutamatergic neurons augments VGCC properties. 
(A) Relationships of IBa current density in glutamatergic neurons co-transfected with pSuper SNAP-25 
siRNA and GFP, pSuper scrambled siRNA and GFP, or GFP alone.  (B) Voltage dependence of steady-state 
activation of isolated P/Q-type current in glutamatergic neurons co-transfected with pSuper SNAP-25 and 
GFP or GFP alone.  (C) Voltage dependence of steady-state inactivation of isolated P/Q-type current in 
glutamatergic neurons co-transfected with pSuper SNAP-25 and GFP or GFP alone.  
 
Moreover it was found that VGCC current densities in glutamatergic neurons from Snap-
25
+/-
 mice were significantly elevated compared to wild type glutamatergic neurons, while 
VGCC current densities in GABAergic were similar between wild type and Snap-25
+/-
 
neurons (Fig. 19). Notably, no difference in the expression of the CaV2.1 P/Q channels or 
the 22 auxiliary subunit of VGCCs were detected in membrane fractions obtained from 
wild-type or heterozygous mouse brains, thus excluding the possibility that reduced SNAP-
25 levels may induce altered VGCC expression, leading to the increased calcium currents 
observed in Snap-25
+/-
 neurons (Fig. 20). 
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Figure 19. VGCC properties in wild type and Snap-25 heterozygous mouse neurons. (A) Mean I-V 
relationships of IBa current density in wild type (n = 12) and Snap-25
+/-
 (n = 12) glutamatergic neurons. (B) 
Mean I-V relationships of IBa current density in wild type (n = 9) and Snap-25
+/-
 (n = 9) GABAergic neurons. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Membrane fractions prepared from heterozygous samples (het) contain reduced levels of SNAP-
25 but comparable levels of the NMDA receptor subunits NR1 and NR2A, relative to wild type (WT). Note 
the equivalent expression of the CaV2.1 P/Q channels and the α2δ2 auxiliary subunit of VGCCs in wild-type 
and heterozygous fractions. 
 
 
To investigate whether the changes in VGCC current between glutamatergic and 
GABAergic neurons (Condliffe et al., 2010 and 2011) could impact neurotransmission, 
synaptic properties were investigated in Snap-25
+/+
 and Snap-25
+/- 
hippocampal cultures 
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(Antonucci et al., submitted). This recent paper of our group demonstrated that there is a 
selective enhancement of evoked glutamatergic currents in 14 DIV old Snap-25 
heterozygous neurons, but no alterations in spontaneous glutamatergic release (Fig. 21), 
synaptic vesicle readily releasable pool, and the overall number of synapses was observed.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. (A,B) Representative traces of mEPSCs and mIPSCs from 14 DIV wt or het neurons followed by 
the quantitative analysis of miniature frequency and amplitude. (C,D) Representative traces of eEPSCs (C) 
and eIPSC (D) from div 14 - wt or het neurons. (E) Quantitative analysis of evoked events after a single 
depolarizing stimulus (from Antonucci et al., submitted). 
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Furthermore, it was noticed a switch from paired pulse facilitation to paired pulse 
depression in Snap-25 heterozygous neurons, indicating an increase in presynaptic release 
probability (Fig. 22) . The change in paired pulse ratio was a direct consequence of lower 
SNAP-25 levels in the presynaptic neuron, as acute reduction of the protein by siRNA 
specifically in the presynaptic, but not in the postsynaptic element, shifts paired pulse 
facilitation to paired-pulse depression. These data indicated that substantial reductions of 
SNAP-25 expression mediate increased probability of release specifically at glutamatergic 
but not GABAergic synapses, possibly leading to a prominent imbalance between 
inhibitory and excitatory neurotransmission. 
 
 
 
 
 
 
 
 
 
 
Figure 22. Shift from paired pulse facilitation to paired pulse depression at 14 DIV hippocampal Snap-25 het 
synapses. (A, B) Representative traces of short term plasticity experiments performed in DIV 14 synaptic 
pairs where the presynaptic glutamatergic or GABAergic neuron was stimulated by two consecutive stimuli. 
(C) Measurement of Paired Pulse Ratio (PPR= P2/P1) at glutamatergic synapses (N=4, t-test p<0,001) and at 
GABAergic synapses (N=4, t-test p<0,001). 
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THE SNAP-25
+/-
 MOUSE MODEL 
 
In order to investigate the physiological role of SNAP-25 and the different functions of the 
alternatively spliced isoforms SNAP-25a and SNAP-25b, a number of gene-targeted 
mouse mutants for Snap-25 have been generated (reviewed in Bark, 2009). 
In particular,  Washbourne and colleagues have examined the involvement of SNAP-25 in 
neuronal exocytosis by generating  SNAP-25 null mutant mice. The mutation was 
generated by targeted gene replacement: the region containing both exon 5a and 5b, 
defined by NsiI and AvrII sites, was replaced by PGKneo, thus disrupting both 
alternatively spliced isoforms of the protein (Fig. 23). The targeting construct was 
transfected into ES cells and four ES cell lines which appeared to have undergone 
homologous recombination were injected into C57BL/6 blastocysts and the chimeric mice 
were backcrossed onto a C57BL/6J background for 4-5 generations (Washbourne et al., 
2002). Mice heterozygous for the Snap-25 mutation are robust, fertile and phenotypically 
indistinguishable from wild-type littermates. In contrast, no homozygous mutants can be 
obtained from heterozygote crosses, consistent with an embryonic lethal phenotype; 
examination of mutant diaphragms shows that while muscle fibers are innervated by the 
respiratory phrenic nerve, they failed to exhibit stimulus-evoked contraction, suggesting 
that the lethality at birth is a consequence of respiratory failure (Washbourne et al., 2002). 
 
 
 
Figure 23. Generation of Snap-25 mutated construct. Both alternatively spliced forms of exon 5 were 
disrupted in the target construct, thus ensuring a reduction in the production of both SNAP-25a and SNAP-
25b proteins (modified from Washbourne et al., 2002).  
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Western blot analysis of E17.5 brains shows a dose-dependent loss of SNAP-25 protein in 
heterozygote and homozygote mutants, while neither the abnormally spliced mRNA 
(abnormal splicing of exon 4 to 6 in the absence of exon 5 should lead to a shift in open 
reading frame with termination after one codon into exon 6) nor the truncated polypeptide 
accumulate to a significant level in mutant fetal brain. Moreover, a survey of presynaptic 
proteins reveales no detectable difference in the expression among wild-type, heterozygote 
and homozygous mutants (Washbourne et al., 2002) (Fig. 24). 
 
 
 
Figure 24. Western blot analysis of E17.5 forebrain shows no dramatic differences in levels of expression of 
synaptic proteins. Importantly, SNAP-23, the non-neuronal homolog of SNAP-25, is not significantly 
induced in the Snap-25 null mutant brain (from Washbourne et al., 2002).  
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SNAP-25 IN NEUROPSYCHIATRIC DISORDERS 
In the last years data accumulated suggesting that SNAP-25 is involved in different 
neuropsychiatric and neurological disorders; alterations in SNAP-25 isoform expression 
have been linked to diseases with developmental onset such as schizophrenia, attention 
deficit hyperactivity disorder, epilepsy and autism. Recent genetic studies of human 
populations and of some mouse models implicate that alterations in Snap-25 gene structure, 
expression and/or function may contribute directly to these distinct neuropsychiatric and 
neurological disorders. Further studies are required to clarify if the changes in SNAP-25 
expression may rapresent a cause or be a consequence of the pathologies. 
 
SNAP-25 IN ADHD 
Attention-deficit/hyperactivity disorder (ADHD) is a frequently diagnosed 
neuropsychiatric disorder in childhood, with worldwide prevalence estimated as 5.3% 
(Polanczyk et al., 2007). Although for many years it was believed to be a disorder of 
childhood and adolescence, it is now recognized to also occur in adulthood. It is 
characterized by a developmentally inappropriate and pervasive expression of inattention, 
impulsivity, and hyperactivity. Evidence from several neurobiological studies supports the 
idea that dysregulation of the catecholaminergic systems underlies ADHD neurobiology 
(Genro et al., 2010; Volkow et al., 2009). Neuroimaging studies in children with ADHD 
also show neurodevelopmental brain anomalies, such as reduced cortical volume and 
folding and gray matter heterotopia, which indicate that, neuroanatomically, ADHD is a 
disorder of early brain development (Shaw et al., 2009). Although the involvement of 
dopamine in ADHD has been consistently suggested in the literature, genetic linkage and 
association studies have identified neurodevelopmental genes other than dopamine-related 
genes as possible candidates for this disorder.  
The primary cause for ADHD is hypothesized to be altered neurotransmission, therefore 
genes encoding synaptic proteins involved in the release of neurotransmitters into the 
synaptic cleft are particularly interesting candidates (Brookes et al. 2005). One of these 
candidates is the gene for the synaptosomal associated protein SNAP-25. Human Snap-25 
gene is located on chromosome 20p11.2. The gene for SNAP-25 is suggested as a 
candidate gene for ADHD based on the mouse mutant strain Coloboma. The mutation in 
the Coloboma mouse involves a 2 cM deletion of chromosome 2p, a region that 
encompasses several genes, including Snap-25. This deletion of the Snap-25 gene results in 
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50% lower amounts of the SNAP-25 mRNA and protein expression compared to wild-type 
mice. Interestingly, Coloboma mutant mice possess several phenotypic characteristics that 
parallel ADHD symptoms. Coloboma mice exhibit normal circadian rhythm and, as 
children with ADHD, they are hyperactive during their active (nocturnal) phase, with 
locomotor activity averaging three fold the activity of control littermates. The specific role 
of SNAP-25 in the hyperactive phenotype has been confirmed by the amelioration of the 
hyperactivity when the deleted Snap-25 gene is replaced with a transgene of Snap-25 (Hess 
et al., 1996). The mechanisms underlying the behavior of these mice appear to be the result 
of dysregulation of the controlled release of neurotransmitters in selected brain regions. 
Another interesting finding of the Coloboma strain is that administration of 
dextroamphetamine, reduces locomotor activity (Raber et al., 1997; Jones et al., 2001). 
Based on this first observation and supported by further behavioural and neurochemical 
analyses in the Coloboma mutant mouse (Heyser et al., 1995; Bruno et al., 2007), 
polymorphisms at the Snap-25 gene locus in humans have been examined and association 
of SNAP-25 with ADHD has been determined in a number of linkage studies (Corradini et 
al., 2009; Zhang et al., 2011; Sarkar et al., 2012). 
 
SNAP-25 IN SCHIZOPHRENIA 
Schizophrenia is a chronic debilitating mental disorder affecting approximately 1% of the 
population worldwide, with the onset of symptoms in late adolescence or early adulthood. 
The clinical symptoms can be classified into two main categories: psychotic or „positive‟ 
symptoms, including hallucinations, altered emotional activity, and disorganized 
behaviour, and „negative‟ symptoms, such as delusions, reduced interest and motivation 
and cognitive impairment. Despite pharmacological treatments, outcomes are variable and 
approximately two-thirds of affected individuals have persistent symptoms with only 
partial remission (American Psychiatric Association, 1994). Schizophrenia is thought to be 
a neurodevelopmental disease characterized by defective connectivity in various brain 
regions during early life (Rehn and Rees, 2005; Lang et al., 2007;  Walsh et al., 2008), but 
the neuropathophysiology of  the disorder remains unclear, although as in the case of 
ADHD alterations in dopaminergic and serotoninergic circuitry, as well as in glutamatergic 
transmission have been strongly implicated. Recent studies provide evidence that there is a 
marked reduction, damage and loss of oligodendrocytes in the prefrontal cortex in 
schizophrenia (Vostrikov et al., 2008) and that the use of antipsychotics can influence 
subsequent myelination (Bartzokis et al., 2009). On the other side Harrison and  
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Weinberger (2005) have supposed that genetic factors influence the schizophrenic 
phenotype by a functional effect on synaptic plasticity and the development of cortical 
microcircuitary. The chromosome region which includes the Snap-25 gene (20p12.3-11), 
emerged as a strong candidate region for schizophrenia as a result of genome-wide 
association studies for susceptibility genes in schizophrenia (Lewis et al., 2003). Studies of 
different parts of the brain in patients with schizophrenia (Hurt et al., 2002) demonstrated 
low levels of SNAP-25 in the cerebellum and  hippocampus. Increased levels of this 
protein were seen in the cerebrospinal fluid of schizophrenia patients, and correlations 
were found between the level of this protein and the severity of psychotic symptoms and 
the occurrence of thought disorders (Thompson et al., 2003). Decreases in the mRNA level 
were also found in various parts of the brains in post mortem studies of patients with 
bipolar affective disorder (Scarr et al., 2006). It has been suggested that these discrepancies 
in altered expression between different brain regions may not only reflect the depressed 
functionality of certain neural circuits, but also the hyperactivity of other pathways that 
may possibly result from compensatory mechanisms elicited through the 
neuropathophysiology of this disorder (Thompson et al., 2003). 
Recently, it has been characterized the blind-drunk mutant mouse which show a dominant 
mutation in a highly conserved domain of SNAP-25. This mutation results in increased 
SNARE binding affinities, impairment of the exocytotic vesicle recycling process, reduced 
glutamate release and a reduction in evoked cortical excitatory post-synaptic potentials 
(EPSPs). This mouse also exhibits many aspects associated with schizophrenia, like 
impairment in sensorimotor gating, high anxiety and apathetic behaviors (Jeans et al., 
2007). Another study on the schizophrenia susceptibility gene DTNBP1 demonstrated that 
the overexpression of dysbindin increase the expression of SNAP-25 in primary cortical 
neuronal culture (Numakawa et al., 2004). 
 
SNAP-25 IN EPILEPSY 
Epilepsy is one of the most common neurological disorders that affects more than 65 
million people worldwide of all ages, with onset most often occurring in childhood and 
older adulthood. It is characterized by the repeated occurrence of spontaneous bursts of 
neuronal overactivity, known as seizures. These seizures differ from person to person with 
respect to their cause and severity, the areas of the brain involved, the location and 
functions of the body affected, the effectiveness of medications and other treatments, and 
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many other factors. Based on electroencephalographic recordings, seizures can be 
classified into two major categories: (1) focal seizures that originate in a network of 
neurons limited to one hemisphere of the brain and (2) generalized seizures that originate 
in a network of neurons that is distributed to both brain hemispheres (Berg et al., 2010). 
Generalized epileptic syndromes can be further classified into symptomatic (caused by 
identifiable factors) or idiopathic (without a clear ethiology and partially caused by genetic 
defects) (Fisher et al., 2005). Generalized idiopathic epilepsies include childhood absence 
epilepsy and juvenile absence epilepsy. These are typically short in duration and manifest 
themselves as sudden behavioral arrest and impaired consciousness The electrographic 
hallmark are spike and wave discharges (SWDs), that arise from synchronous firing of 
thalamocortical networks (Blumenfeld et al., 2005). Several analysis on absence epilepsy 
revealed a strong causal link to mutations in various types of voltage-gated and ligand-
gated ion channels, including voltage-gated potassium, sodium, and calcium channels, as 
well as GABAA receptors (Mulley et al., 2005; Helbig et al., 2008). Analysis in absence 
epileptic mice models, like Tottering, Leaner and Rolling Nagoya mice, revealed mutation 
that results in decreased P/Q-type current density (Fletcher et al., 1996; Wakamori et al., 
1998).  
Interestingly, the mutant mouse Coloboma (Cm/+), which has been implicated as a model 
of ADHD, has also provided evidence for the involvement of SNAP-25 in epilepsy. Cm/+ 
mice display robust cortical cortical spike-wave discharges and increased thalamic T-type 
currents (Zhang et al., 2004), two typical features of  absence epilepsy (Tsakiridou et al., 
1995; Coenen and Van Luijtelaar, 2003). SNAP-25 is expressed at much higher levels at 
excitatory respect to inhibitory synapses (Verderio et al., 2004; Bragina et al., 2007). Thus, 
hyperexcitability could result from perturbations of the processes that balance the 
developmental assembly of inhibitory and excitatory circuits. Recent evidence indicates an 
additional function of SNAP-25 in the modulation of various ion channels, in particular 
this protein have a role in the regulation of calcium homeostasis in neurons. It has been 
shown that phosphorylated SNAP-25 negatively modulates calcium dynamics by inhibiting 
voltage-gated calcium channels (Verderio et al., 2004; Pozzi et al., 2008). In addition 
Condliffe et al. demonstrated that endogenous SNAP-25 negatively regulates native VGCC 
in glutamatergic neurons, therefore the regulation of SNAP-25 may have a crucial role in 
the control of normal neuronal network activity (Condliffe et al., 2010). 
Recently, based on the conclusion that the phosphorylation of SNAP-25 plays an important 
role in synaptic function, it was generated a mutant mouse, substituting Ser
187
 of SNAP-25 
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with Ala (Kataoka et al., 2011). The most striking effect of the mutation was observed in 
behavior. The homozygous mutant mice froze readily in response to environmental 
change, and showed strong anxiety-related behavior in general activity and light and dark 
preference tests. In addition, the mutant mice sometimes exhibited spontaneously occurring 
convulsive seizures. All these results confirm the relevance of PKC-dependent SNAP-25 
phosphorylation. 
 
SNAP-25 IN AUTISM 
Autism spectrum disorders (ASD) represent complex neurodevelopmental disorders 
characterized by limited social interactions, abnormal use of language and stereotyped 
patterns of behavior, interests, and activities. ASD are heterogeneous disorders with a wide 
range of additional phenotypic characteristics and an intelligence quotient (IQ) ranging 
from mental retardation to above average. There are three main subtypes of ASD: classical 
autism (autistic disorder), asperger disorder (high functioning) and pervasive 
developmental disorder not otherwise specified (PDD-NOS) (American Psychiatric 
Association 2000). The prevalence of affecting  is 1 in 110 children with a 4.5:1 male to 
female ratio. The first behavioral signs of social impairment may appear usually between 1 
and 2 years of age and the final diagnosis is commonly made by 2-4 years of age 
(Chourchesne et al., 2007). Symptoms of ASD  are frequently accompanied by intellectual 
disability (ID) (75%), dysmorphic features, epilepsy (25%), but also attention deficit, 
hyperactivity and impulsivity which are clinical features shared with attention deficit 
hyperactivity disorder (ADHD) (40–78%) (Murray et al. 2010). The etiology of ASD is 
still not clear, but several evidence show a diversity of morphological, functional, genetic, 
and neurotransmitter systems alterations. Family studies suggest that genetic factors 
contribute significantly to autism (up to 90%). In less than 20 percent of subjects are 
identifiable monogenic causes, the remaining individuals have other genetic or multigenic 
causes and/or epigenetic influences which are environmental factors altering gene 
expression without changing the DNA sequence (Piven et al., 1997). Post-mortem studies 
have demonstrated altered early neurodevelopmental alterations in brains of autistic 
patients including reduced programmed cell death and/or increased cell proliferation, 
altered cell migration, abnormal cell differentiation with reduced neuronal size and altered 
synaptogenesis (Persico et al., 2006; Bauman et al., 2005). Furthermore it has been 
proposed that dysregulated Ca
2+
 levels may be a broadly influential factor in causing 
autism (Napolioni et al., 2011). A very recent paper (Guerini et al., 2011) investigated the 
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possibility that SNAP-25 plays a role in ASD by analyzing five Snap-25 gene 
polymorphisms, rs363043, rs363039, rs363050, rs3746544 and rs1051312, in a well 
clinically characterized cohort of children affected by ASD. They found a significant 
association of the rs363043 (C/T) genotype with increasing Childhood Autism Rating 
Scale (CARS) scores in a cohort of children with a diagnosis of ASD, supporting a role for 
Snap-25 as a new gene involved in the genetic background of ASD (Fig. 25). 
 
 
 
 
 
 
Figure 25. Polymorphism rs363043 is localized in the intron 1 of the Snap-25 gene which regulates protein 
expression (from Guerini et al., 2011). 
 
POLYMORPHISMS IN SNAP-25 GENE 
Point of variation or polymorphisms are the source of genetic variation that contribute to 
differences between individuals, and, thus, are the focus of attention for molecular genetic 
studies. There are several types of polymorphisms, though two commonly studied types are 
repeat sequences and single-nucleotide polymorphisms (SNPs). Repeat sequences consist 
of a set of bp that can be short in length (i.e., 2-4 bp) or quite long (i.e., 10-60 bp), and the 
different variants of the polymorphism, or alleles, are defined as how many times the 
sequence is repeated (e.g., two-repeats vs. four-repeats vs. seven-repeats). A SNP consists 
in a DNA sequence variation that occurs when a single nucleotide (A,T,C,or G) in the 
genome sequence is altered; to be classified as polymorphism, the variation must occur in 
at least 1% of the population.  
In the human genome SNPs occur in just about every 3000 base pairs (Cargill et al., 1999) 
and the frequency of occurrence of the different alleles changes in different populations. 
The human genome is estimated to contain around 25‟000 genes, each of which is 
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responsible for the production of a specific protein. The structure of a gene consists of a 
promoter region that is involved in the initiation of transcription of the gene, a process that 
ultimately leads to the production of the gene product, and the gene sequence itself. The 
gene sequence consists of exons, which are elements responsible for the coding of proteins, 
and introns, which are not involved in the coding of proteins. As a result, polymorphisms 
that lie within the exons are the most likely to result in functional changes in the gene 
product, though recent research suggests that polymorphisms in the promoter region and 
introns may also result in functional changes in the gene product and may play a role in 
regulating gene expression. A number of polymorphisms have been implicated in different 
neuropsychiatric and neurological disorder. Polymorphisms in neurological disorder with a 
central immune component are well described, mainly due to their role in increasing 
neurodegeneration. In contrast, polymorphisms resulting in or affecting psychiatric 
disorders are less well studied and frequently are not replicated by meta-analysis. 
Furthermore, even if a significant association has been confirmed, the role of the identified 
polymorphism in causing and/or augmenting the disorder is often difficult to rationalize. 
Recently mounting evidence has revealed an association between SNAP-25 and ADHD in 
humans, although the alleles and polymorphisms associated with this disorder were not 
consistent across studies. Initially Barr and collegues identified two polimorphisms 
mapped to Snap-25, 1065 (T/G) and 1069 (T/C), as possible sites for association between 
ADHD and Snap-25 gene (Barr et al., 2000). In 2002, Mill suggested that tetranucleotide 
repeat polymorphism (TAAA - 13 repeats) may have a role in the expression or function of 
Snap-25 gene and that there could be an association between the rs363006 SNP and 
ADHD (Mill et al., 2002 and 2004). In contrast Feng et al., (2005) did not identify any 
linkage with this polymorphism, but showed a strong relation with rs362549. Later the first 
report of an association between SNAP-25 and ADHD in Chinese subjects of Han descen 
was published. Zhang‟s group detected the transmission disequilibrium phenomenon of 
ADHD‟s different subtypes on rs362549 fragment of SNP; they hypothesized that the 
allele G in rs362549 fragments may be a Snap-25 risk allele which may cause increased 
hyperactivity. Other similar association tests were performed between SNPs of Snap-25 
gene and schizophrenia. One previous single-marker association study was negative 
(Tachikawa et al., 2001), however few years later Lezheiko studied two markers (MnlI and 
DdeI, or T1065G and T1069C, respectively) and an association between the T1065G 
polymorphism of the Snap-25 gene with the effectiveness of performing neurocognitive 
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tests was seen not only in schizophrenia patients, but also in mentally healthy subjects 
(Lezheiko, 2007). Following a paper revealed an linkage between one of markers (DdeI) 
and the overall level of cognitive functioning in patients and measures of executive 
functions and verbal memory (Spellmann et al., 2008). 
Learning and memory are key components of human intelligence and the Snap-25 gene 
lies in an area of previous suggestive linkage to intelligence (Posthuma et al. 2005). 
Recently, a family-based genetic association test, performed in two independent cohorts of 
Caucasian children and adults, has  evidenced association between four Snap-25 single 
nucleotide polymorphisms (SNPs) and variation in IQ phenotypes across both cohorts. The 
four SNPs (rs363043, rs353016, rs363039, rs363050) are localized within intron 1, in a 
region of about 13.8 kb, and are known to affect transcription factor binding sites (Gosso et 
al. 2008). The SNP rs363050, in particular, is associated with better results in the 
performance subtests of the Weschler intelligence scale and the increased allelic frequency 
of this SNP was associated with an increase of nonverbal cognitive skills (Gosso et al. 
2006). Furthermore, in recent years, it has been proposed that a different distribution of 
SNAP-25 protein in male or female brains may be involved in gender differences that 
characterize many neuropsychological skills in neuropsychiatric diseases such as ADHD 
and ASD (Ghezzo et al. 2009). 
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AIM OF THE PROJECT 
SNAP-25 is a member of the SNARE protein complex that participates in synaptic vesicle 
exocytosis. Previous studies have demonstrated that SNAP-25, which is expressed at high 
levels in glutamatergic but not GABAergic terminals of hippocampal neurons (Verderio et 
al., 2004), regulates intracellular calcium dynamics by negatively modulating neuronal 
voltage-gated calcium channels upon SNAP-25 activity-dependent phosphorylation on 
Ser187 (Pozzi et al., 2008,  Condliffe et al., 2010). Reductions of SNAP-25 expression, 
inducing increases of calcium responsiveness specifically in glutamatergic neurons, may 
thus lead to unbalances in neuronal network activity, possibly resulting in a pathological 
state. In line with this possibility, alterations of SNAP-25 expression have been associated 
to several neurological diseases, such as schizophrenia, ADHD, and bipolar disorder, and 
lower levels of SNAP-25 have been described in patients with schizophrenia (Thompson et 
al., 2003). During my PhD project, I used Snap-25 heterozygous (Snap-25
+/−
) mice, 
expressing reduced levels of SNAP-25, to investigate at which extent the reduction of the 
protein expression affects neuronal network function and mouse behaviour. Since reduced 
levels of SNAP-25 in humans might be  a consequence of the presence of polymorphisms 
regulating transcriptional activity of the gene, and given a strong association between three 
polymorphisms in the Snap-25 gene (rs363039, rs363050 and rs363043) and intelligence 
has been recently demonstrated (Posthuma et al. 2005), in the second part of my PhD I 
carried out a functional analysis on SNP rs363050, located on  intron 1 of the Snap-25 
gene, to investigate whether the presence of the parental or minor allele may affect the 
expression of SNAP-25. 
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EXPERIMENTAL PROCEDURES 
ANIMALS 
Male Snap-25
+/+
 and Snap-25
+/−
 C57BL/6 mice, originally from M.C. Wilson (University 
of New Mexico Health Sciences Center, Albuquerque, NM, USA), were provided by J. 
Sorensen (MPI, Goettingen). Mice were maintained and repeatedly backcrossed on 
C57BL/6 background for more than 10 generations. Zero- to six-month-old age-matched 
littermate mice were used. All the experimental procedures followed the guidelines 
established by the Italian Council on Animal Care and were approved by the Italian 
Government decree No. 27/2010. All efforts were made to minimize the number of 
subjects used and their suffering. Mice were individually housed throughout the testing 
period with free access to food and water at controlled temperature (20–22 °C) with a 12-h 
light/dark cycle (lights on at 7:00 AM). Genotyping was performed by PCR, using DNA 
extracted by tail biopsy. 
 
Gene Primer sense Primer Antisense 
Snap-25 CGAAGAAGGCATGAACCATATCAAC GCCCGCAGAATTTTCCTAGTTCCG 
Neomycin GCACGCAGGTTCTCCGGCCGC TCAAGCGTATGCAGCCGCCGC 
 
 
WESTERN BLOTTING 
Detection of neuronal proteins in cortex homogenates from E18, P7, P14, P30, and adult (3 
months old) mice. Homogenates of mouse brain cortex obtained from Snap-25
+/-
 and 
control mice were separated by electrophoresis, blotted,
 
and incubated with primary 
antibody, followed by HRP-conjugated
 
secondary antibody (Jackson ImmunoResearch, 
West Grove, PA),
 
and developed by ECL (Amersham Biosciences, Amersham, UK). The 
following primary antibodies were used: monoclonal antibdsies directed against SNAP-25 
(Sternberger Monoclonals Inc., Baltimore, MD), PSD95 (NeuroMab, Davis, CA), 
IIITubulin (Promega, Milano), alpha-Tubulin (Sigma-Aldrich, St. Louis, MO), NMDAR1 
(SySy, Goettingen, Germany), vGlut1 1:2000 (Synaptic System, Gottingen, Germany); 
polyclonal antibodies against Calbindin (Swant, Bellinzona, Switzerland), NMDAR2A 
(Zymed Laboratories, San Francisco, CA). Antibodies against SNAP-47, SNAP-29, and 
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SNAP-23 were a gift of R. Jahn (MPI, Gottingen). Beta-III tubulin or alpha-tubulin was 
used as loading controls. 
 
 
qRT-PCR ANALYSIS 
Brain tissues from P7, P14, P30, and adult mice were used for realtime PCR analysis. 
Sample was homogenized prior to RNA extraction in 800 μL of Trizol. Total RNA was 
isolated using the NucleoSpin miRNA (Macherey-Nagel GmbH &Co., Düren, Germany) 
isolation kit according to the manufacturer‟s protocol. The RNA was eluted with 30-μL 
Rnase-free water. All RNA was quantified by spectrophotometer and optical density 
260/280 nm ratios were determined. Reverse transcription was performed on 2 μg RNA 
using Superscript III First-Strand Synthesis System and random hexamer primers (Life 
Technologies, Carlsbad CA, USA). Real-time polymerase chain reaction (qRT-PCR) was 
performed using 7900 HT fast-real-time PCR system instrument (Life Technologies, 
Carlsbad CA, USA). The amplification was carried out in a total reaction volume of 11 μL, 
using the TaqMan Gene Expression Master Mix (Life Technologies, Carlsbad CA, USA). 
Predeveloped TaqMan Assay Reagent (FAM-MGB) for Snap-25 (Mm00456921_m1) and 
for GAPDH (4352339E) were purchased from PE Applied Biosystems. Each gene was 
analyzed in triplicate. Data analysis was performed with the ΔΔCt method. All RNA levels 
were normalized to Gapdh. 
 
BRAIN SLICES AND IMMUNOHISTOCHEMISTRY 
Experiments were performed on 5 Snap-25
+/+
 and 3 Snap-25
+/−
 mice at postnatal day (P) 2 
and on 3 Snap-25
+/+
 and 3 Snap-25
+/−
 adult (P90) mice. All the experiments were 
undertaken in accordance with the guidelines established in the Principles of Laboratory 
Animal Care (directive 86/609/EEC). All efforts were made to reduce the number of 
animals used and to minimize their suffering. Animals were anesthetized with chloral 
hydrate (4%; 1 ml/100 g body weight, i.p.) and perfused transcardially with 4% 
paraformaldehyde in 0,1 M phosphate buffer, pH 7.2 (see Frassoni, 2000 for details). The 
forebrains were dissected out and coronally cut with a Vibratome or with a freezing 
microtome in serial sections. The following antibodies were used: monoclonal anti-non-
phosphorilated neurofilaments (SMI311, Sternberger Monoclonals Inc., Baltimore, MD), 
vGlut1 (Synaptic System, Gottingen), vGlut2 (Synaptic System, Gottingen); polyclonal 
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antibodies against the calcium-binding proteins calbindin and calretinin (CB and CR; 
Swant, Bellinzona, Switzerland), doublecortin (DCX, Cell Signalling, Beverly, MA), the 
neuropeptide Y (NPY) (Bachem, Weil am Rhein, Germany) and vGat (Synaptic System, 
Gottingen). Free-floating sections were preincubated for 45 min in 0.01 M phosphate 
buffered saline pH 7.4, containing 10% normal goat serum and 0.2% Triton X-100 and 
then incubated with primary antibodies. Subsequently the sections were incubated in the 
corresponding secondary antibodies (Jackson Immunoresearch Laboratories, West Grove, 
PA, USA) and signals were revealed with appropriate biotinylated secondary antibodies 
(Vector Laboratories, Burlingame, CA, USA) followed by avidin–biotin–peroxidase 
complex (ABC kit, Vector Laboratories, Burlingame, CA, USA) and diaminobenzidine 
(DAB). For cytoarchitectonic analysis, selected sections were stained with thionin (0.1% in 
distilled water). 
 
BEHAVIORAL TESTS 
SPONTANEOUS MOTOR ACTIVITY  
Spontaneous motor activity was carried out as previously described (Braida and Sala, 
2000) in an activity cage (43 × 43 × 32 cm) (Ugo Basile, Varese, Italy), placed in a sound 
attenuating room. The cage was fitted with two parallel horizontal infrared beams located 2 
cm from the floor. Cumulative horizontal movement counts were recorded for 15 min. 
Before the start of the test, Snap-25
+/+
 and Snap-25
+/−
 mice (7–9 weeks of age) were 
habituated to the testing room for at least 1 h. The reflex was considered positive when a 
rapid movement of the whole body of the animal was clearly noticed as previously 
described (Jero et al. 2001). Cumulative horizontal and vertical movement counts were 
recorded for 4 h. 
 
EEG RECORDINGS 
Mice were anesthetized with intraperitoneal (i.p.) injection of 5% chloral hydrate dissolved 
in saline and given in a volume of 10 ml/kg body mass. Four screw electrodes (Bilaney 
Consultants GMBH, Dusseldorf, Germany) were inserted bilaterally through the skull over 
cortex (anteroposterior, +2.0 –3.0 mm; left-right 2.0 mm from bregma) according to brain 
atlas coordinates (Paxinos and Franklin, 2004); a further electrode was placed into the 
nasal bone as ground. The five electrodes were connected to a pedestal (Bilaney, 
Dusseldorf, Germany) and fixed with acrylic cement (Palavit, New Galetti and Rossi, 
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Milan, Italy). The animals were allowed a week of recovery from surgery before starting 
the experiment and acclimatized to a sound-attenuated Faraday chamber for a period of 3 
days. For the assessment of basal cerebral activity, freely moving mice were recorded 
continuously for 24h using PowerLab System (ADInstruments, Castle Hill, Australia). For 
each 24-h EEG recording, the mean number of spikes was evaluated in both genotypes. 
After the recordings, the EEG and video (through a video camera put inside the Faraday 
chamber) were analyzed for the incidence/duration of spontaneous cortical spike activity 
and the percentage of animals displaying spike activity, as previously described (Zhang et 
al. 2004; Manfredi et al. 2009). 
 
BEHAVIORAL OBSERVATION OF KA-INDUCED SEIZURES 
Kainic acid (KA, Sigma) was dissolved in saline and administered i.p. at 35 mg/kg body 
weight. Saline-injected animals of both genotypes were used as controls. Ten wild-type 
and 10 Snap-25
+/−
 mice were used. In all experiments, the experimenter was blind to the 
genotype of the animals. Seizure severity was determined according to Racine‟s scale 
(Racine, 1972): stage 0: normal behavior; stage 1: immobility; stage 2: forelimb and/or tail 
extension, rigid posture; stage 3: repetitive movements, head bobbing; stage 4: forelimb 
clonus with rearing and falling (limbic motor seizure); stage 5: continuous rearing and 
falling; stage 6: severe whole body convulsions (tonic-clonic seizures); stage 7: death. For 
each animal, the rating scale value was scored every twenty minutes for a maximum of 3 
hr after KA administration. The maximum rating scale values reached by each animal over 
each 20 min interval were used to calculate the rating scale value (± SE) for each treatment 
group. Statistical analysis was performed by two-way repeated measures ANOVA 
followed by post-hoc Holm-Sidak test. At the end of behavioral observation (3 hr after 
KA), animal were returned to their home cages; animals were killed at 14 days after KA 
for histopathological analyses. 
 
QUANTIFICATION OF NPY STAINING 
The quantification method was adapted from that described in Antonucci et al., 2008. 
Four-eight NPY-stained sections through the dorsal hippocampus were analyzed in each 
KA-treated mouse (wild type [wt], n = 5; heterozygous [het], n = 5). Images of CA3 
stratum radiatum and of the overlying corpus callosum in each hemisphere were digitized 
(Zeiss Axiovision). Light intensity and microscope settings were optimized initially and 
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then held constant. Care was taken to avoid saturation at either end of the pixel intensity 
range (0–255). Mean signal intensity in the CA3 stratum radiatum was divided by the 
background labeling in each section (calculated in the callosum of each hemisphere). For 
each animal, an NPY staining score was obtained by averaging the values obtained in 
individual sections. The NPY staining score was then correlated to the maximum 
behavioral seizure core recorded for each mouse following KA treatment. Pearson 
correlation analysis was performed using SigmaPlot 11.0. 
 
TWO-BOTTLE PREFERENCE TEST 
2-bottle preference test were performed as previously described (Bruno et al. 2007). A 
cohort of 10 Snap-25
+/-
 mice had access to plain water and 0.008 M HCl for 30 min each 
morning for 4 consecutive days. The cohort was then tested for water vs. 0.8 mM quinine 
and for plain water versus 0.1% saccharin. Consumption (ml/10g) was measured for 3 days 
(days 2–4) for each test and the mean consumption was analyzed using one-way ANOVA. 
 
NOVEL OBJECT RECOGNITION 
The test was conducted over a two-day period in an open plastic arena (60 x 50 x 30 cm), 
as previously described (Pan et al. 2008). Ten Snap-25
+/+
 and Snap-25
+/−
 mice were used. 
Animals were habituated to the test arena for 10 min on the first day. After 1-day 
habituation, mice were subjected to familiarization (T1) and novel object recognition (T2). 
During the initial familiarization stage, two identical objects were placed in the centre of 
the arena equidistant from the walls and from each other. Each mouse was placed in the 
centre of the arena between the two objects for a maximum of 10 min or until it had 
completed 30s of cumulative object exploration. Object recognition was scored when the 
animal was within 0.5 cm of an object with its nose toward the object. Exploration was not 
scored if a mouse reared above the object with its nose in the air or climbed on an object. 
Mice were returned to the home cage after familiarization and retested 120 min later, and 
in the arena a novel object (never seen before) took the place of one of the two familiar. 
Scoring of object recognition was performed in the same manner as during the 
familiarization phase. From mouse to mouse the role (familiar or new object) as well as the 
relative position of the two objects were counterbalanced and randomly permuted. The 
objects for mice to discriminate consisted of white plastic cylinders, coloured plastic Lego 
stacks of different shape and a metallic miniature car. The arena was cleaned with 70% 
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ethanol after each trial. The basic measure was the time (in s) taken by the mice to explore 
the objects in the two trials.The performance was evaluated by calculating a discrimination 
index (N-F/N+F), where n= time spent exploring the new object during T2, F= time spent 
exploring the familiar object during T2 (Pitsikas et al. 2001). 
 
CONDITIONED TASTE AVERSION 
Ten Snap-25
+/+
 and twelve Snap-25
+/−
 mice were individually housed during the CTA test. 
After mice were adapted to a restricted drinking schedule (20 min/day for 4 days), they 
were exposed to a saccharin solution (0.5%) followed 1 h later by a malaise-inducing 
injection of LiCl (0.14 M, 2% body weight, i.p.). Beginning 48 h after conditioning, mice 
could freely choose to drink either saccharin solution or tap water during 3 daily choice 
tests (ct1–ct3). The amount of saccharin intake expressed as the percentage of total fluid 
consumed ([saccharin/saccharin +water] × 100) was taken as an aversion index. 
 
SOCIABILITY AND SOCIAL NOVELTY TEST 
The apparatus was a rectangular, three-chamber transparent polycarbonate box 
(width=42.5 cm; height=22.2 cm; centre chamber, length=17.8; side chambers, 
length=19.1 cm). The proband mouse was firstly placed in the middle compartment and 
allowed to explore all three chambers for 10 min (habituation) (Moy et al. 2004, Sala et al. 
2011). An unfamiliar adult DBA/2J male mouse was placed in one side compartment 
whereas the opposite contained an empty wire cage. For the social novelty test, carried out 
in the same apparatus without any cleaning, immediately after sociability test, one side 
compartment contained the familiar mouse (from the previous sociability phase), the other 
side an unfamiliar mouse. The new unfamiliar mouse was placed in the wire cage that had 
been empty during the prior 10-min session. Familiar and unfamiliar animals from 
different home cages had never been in physical contact with the subject mice or with each 
other. For both tests, the time spent in each chamber and the number of entries into each 
chamber were recorded for 10 min. Data are expressed as time spent in each chamber or 
the difference score between the time spent to explore the compartment containing the 
conspecific and that spent in the empty compartment (for sociability test), or containing the 
stranger animal (unfamiliar) and that for the familiar mouse (for social novelty test) 
(DeVito et al. 2009). 
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PHARMACOLOGICAL TREATMENT 
One week after basal EEG recording animals were recorded  1 hour before and for 2 hours 
after different drug i.p. treatment: VLP sodium salt (250 mg/kg), ethosuximide (ETO; 200 
mg/kg), carbamazepine (CBZ; 50 mg/kg), and nimodipine (NIMO; 10 mg/kg). VLP was 
given immediately before HCl exposure in the CTA test, 20 min before T1 in the object 
recognition test, and 20 min before sociability and social novelty test. All drugs were 
dissolved in saline whereas nimodipine in 10% ethanol and saline, and CBZ in 1% Tween 
80. The doses of ethosuximide, valproate, carbamazepine and nimodipine were chosen  for  
their ability to suppress seizures, differently induced, in mice (Larkin et al. 1992; DeLorey 
et al. 1998; Liljelund et al. 2005; Shitak et al. 2006; Marrosu et al. 2007; Chung et al. 
2009). All the drugs were given i.p. in a volume of 0.1 mL/10g. Drugs were purchased 
from Sigma-Aldrich (St. Louis, MO). 
 
CELL LINES AND CULTURES 
The SH-SY5Y human neuroblastoma cell line was grown in RPMI 1640 medium, 10% 
fetal calf serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine 
(Lonza). 
 
PLASMID CONSTRUCTIONS 
A 747 bp fragment, spanning region of Snap-25 intron 1 containing the polymorphism A/G 
(rs363050), was amplified by PCR from human genomic DNA (forward primer: 5‟- GGA 
TCC TTA GAC TAG GAT TCA CCA GGC C - 3‟; reverse primer: 5‟- GGA TCC CCC 
AAA GCA GGT GGT AA – 3‟, in which the Bgl II site was added and cloned upstream 
the TK promoter and downstream the luciferase gene in the TK-luc/pGL4 basic reporter 
vector. All restriction enzymes were purchased from NEB (New England Biolabs). At first 
we obtained the plasmid pTK-luc/pGL4basic by digesting the pGL4 basic plasmid DNA 
(Promega) and the TK-luc/pGL3 with Bgl II and Hind III enzymes. The DNA fragment 
containing the TK promoter was inserted into the BglII / HindIII-digested pGL4b. The 
rs363050A-TK-luc and the rs363050G-TK-luc constructs were obtained by cloning the 
747 bp  fragment into the Bgl II site (upstream the TK promoter) and into the Bam HI site 
(downstream the luciferase gene; TK-luc-rs363050A and TK-luc-rs363050G) of pTK-
luc/pGL4b. The correct orientation and the identity of the inserts were verified by 
restriction analysis and DNA sequencing.  
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The constructs containing multimerized copies of a cassette spanning the rs363050 SNAP-
25 polymorphism were obtained by cloning in the  Bgl II and Hind III site, respectively, 
the following oligonucleotides: 
 
gatcttgtgaatgagtgg/atcgggcagcca                Bgl II 
    aacacttactcaccagcccgtcggtctag 
 
agctttgtgaatgagtgg/atcgggcagcca 
    aacacttactcaccagcccgtcggttcga    Hind III  
 
 
in a ligation reaction mix containing the plasmid pTKluc/pGL4 basic digested with Bgl II 
or Hind III and an excess of  oligonucleotides (oligonucleotide:vector, 10:1 ratio) to force 
the insertion of multiple copies. The orientation and the number of inserted copies were 
verified by DNA sequencing. 
 
TRANSIENT TRANSFECTIONS 
The cells were transiently transfected by means of lipofection using 2 x 10
5
 SH-SY5Y 
cells. Briefly, the cells were plated onto a well of a six-multiwell tissue culture plate 
(Euroclone) the day before transfection. 100 ng of pRL-TK were mixed with an equimolar 
amount of the construct of interest and  2 µl of FUGENE HD (Promega). After 20 minutes 
of incubation at room temperature , the DNA-lipid mixture was added to the cells and 
incubated for 48 hr, when luciferase activity was measured. The pRL-TK plasmid 
expresses the Renilla luciferase reporter gene under the control of the thymidine kinase 
minimal promoter and was cotransfected in each sample to normalize for transfection 
efficiency. 
 
FIREFLY LUCIFERASE AND RENILLA LUCIFERASE 
ASSAYS 
Firefly and Renilla luciferase activities were detected by using the Dual-Luciferase 
Reporter Assay System (Promega). The cells were harvested, washed twice in phosphate-
buffered saline (PBS), and detached by means of PBS/EDTA (1mM). After a brief 
centrifugation, the pellet was washed once and lysed in 60 µl of Passive Lysis Buffer 
(Promega) for 20 min at room temperature. The lysate was clarified by centrifugation and  
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20 µl were added to 95 ul of luciferase assay substrate to be tested for Firefly luciferase 
activity in a  Berthold L1920 luminometer for 12 s. The quenching of Firefly luciferase 
luminescence and the concomitant activation of Renilla luciferase were accomplished by 
adding 95 µl of Stop & Go Reagent to the sample tube immediately after quantitation of 
the Firefly luciferase reaction.  
 
DATA ANALYSIS 
The results are given as the mean values  ± standard deviation (SD) of at least three 
independent experiments. The data were analysed by means of a paired two-tailed 
Student‟s t test using GraphPad Prism 4 Software (GraphPad Software, Inc.); p values of 
<0.05 were considered significant. 
 
EMSAs (electrophoretic mobility-shift assays) 
The double-stranded oligonucleotides used in the EMSA were labelled with α32P-dCTP by 
fill-in and purified on a G-25 Sephadex column (Hoffmann-La Roche). Reaction mixtures 
containing 2 μg of BSA, 10 μl of 2× binding buffer [1× binding buffer is 20 mM Hepes, 
pH 7.9, 2 mM MgCl2, 4%Ficoll, 0.5 mM dithiothreitol], 2 μg of double-stranded poly(dI-
dC) (dI-dC) (Sigma-Aldrich), 100 mM final salt concentration (NaCl+KCl)] and 5 µg of 
nuclear extract were assembled in a final volume of 20 μl and pre-incubated for 15 min on 
ice; 10000–20000 c.p.m. of the labelled probes (1 fmol) were added to each reaction. After 
15 min of incubation on ice, the reaction mixtures were loaded onto 0.5× 
Tris/borate/EDTA, 5% non-denaturing polyacrylamide gels (acrylamide/bisacrylamide, 
29:1) and run at a constant voltage of 150 V. Competition experiments and supershifts 
were carried out by pre-incubating the reaction mixtures with the appropriate amounts of 
unlabelled oligonucleotides or antibodies. All the oligonucleotides used in the 
EMSAexperiments were purchased from Sigma-Aldrich.. All of the antibodies were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A). 
 
SNAP-25 rs363050_A  5‟ TGACCTGTGAATGAATGAGTGATCGGGCAG 3‟ 
            3‟ GGACACTTACTTACTCACTAGCCCGTCGG 5‟ 
 
SNAP-25 rs363050_G            5‟ TGACCTGTGAATGAATGAGTGGTCGGGCAG 3‟ 
               3‟ GACACTTACTTACTCACCAGCCCGTCGG 5‟ 
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RESULTS 
EFFECTS OF SNAP-25 REDUCTION IN VIVO 
As previously described, SNAP-25 is not only involved in the formation of the SNARE 
complex, but it also acts as modulator on native VGCCs (Pozzi et al., 2008; Condliffe et al, 
2010). Reduction of the protein levels causes a significant increase of calcium currents and 
calcium dynamics in excitatory, but not inhibitory neurons, generating a prominent 
imbalance between excitatory and inhibitory neurotransmission. Moreover, recent data 
obtained in our lab (Antonucci et al., submitted) show that substantial reductions of SNAP-
25 at the presinaptic level enhance evoked glutamatergic neurotransmission. For this 
reason we focused on the possible effects that altering SNAP-25 expression may have in 
vivo. 
 
Developmental Expression of Snap-25 in Heterozygous Mice Brain 
The heterozygous mice for Snap-25 (Snap-25+/-) generated by Washbourne et al. (2002) 
result in 50% lower amounts of the SNAP-25 mRNA and protein expression compared to 
wild-type mice at embryonic day 17.5 (E17.5; Washbourne et al., 2002). In order to 
confirm SNAP-25 reduction during brain development,  we analyzed the levels of the 
protein at different developmental stages. Western blotting analysis of wild-type and 
heterozygous mice cortices revealed that SNAP-25 and syntaxin progressively increase 
during pre- and postnatal development of the brain. BetaIII-Tubulin and alpha-Tubulin 
were used as loading markers for SNAP-25 quantitation to minimize development-related 
artifacts. The results showed a physiological increase of SNAP-25 in wild-type mice and, 
notably, an enhanced increase of the protein levels in heterozygous mice relatively to Snap-
25+/+ mice, indicating a partial compensation of protein expression during postnatal 
development. The protein increase was not accompanied by a parallel increase in SNAP-25 
mRNA levels, as assessed by qRT-PCR analysis, suggesting that post-transcriptional 
mechanisms may be involved. No significant difference in syntaxin or in growth-
associated protein GAP-43 expression was found between Snap-25+/+ and Snap-25+/- mice 
during development (Fig. 26).  
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Figure 26. SNAP-25 levels in Snap-25+/− cortices progressively increase during postnatal development. (A, 
C, and D) Western blotting analysis (A) and relative quantitation (C and D) of Snap-25+/+ and Snap-25+/− 
cortices from E18, P7, P14, P30 and adult (3 months old) mice reveals a progressively higher expression 
ratio in Snap-25+/− mice during postnatal development. (B) RT-qPCR analysis reveals that SNAP-25 mRNA 
is about half in Snap-25+/− mice at all developmental stages. (E) Quantitation of syntaxin expression at 
different developmental stages shows no differences in the protein expression between Snap-25+/+ and Snap-
25+/− animals. (F) Western blotting analysis of GAP43 expression in mice cortices at early developmental 
stages reveals the absence of differences between Snap-25+/+ and Snap-25+/− mice. 
 
Morphological characterization of Snap-25+/- mouse brains 
Mice heterozygous for the Snap-25 mutation were robust, fertile and phenotypically 
indistinguishable from wild-type littermates. To evaluate the possible effects of SNAP-25 
reduction on brain anatomy, morphological characterization of Snap-25+/− pup (post-natal 
day 2, P2) and adult (P60) brains was performed. Thionine staining revealed the absence of 
major alterations in the main brain structures, cortex, hippocampus, and thalamus of both 
P2 (Fig. 27 A,B) and P60 (Fig. 27 G,H) Snap-25+/− mice. We observe normal cortical plate 
and layers V and VI (Fig. 27 D,F), moreover the thickness of the cortices was comparable, 
as indicated by thionin staining (Fig. 27 I,J). 
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Figure 27. Thionine staining of pup (P2) and adult (P60) Snap-25+/- and control brains. No major structural 
alterations were observed in the brains of P2 (A,B) or P60 (G,H) mice. High magnification of developing 
cortices reveal comparable cortical lamination (D, F); the thickness and layering of the cortices are similar (I, 
J). 
 
Neurogenesis and the cortical lamination occurring in the brains of wild-type and 
heterozygous adult mice were investigated through immunostaining for non-
phosphorylated neurofilaments or for the protein doublecortin (DCX). We used the 
antibody SMI311, which labels a subpopulation of pyramidal cells mainly located in layers 
II–III and V, to evaluate the degree of cortical maturation, and an antibody directed against 
DCX to mark migrating neuronal precursor cells that eventually integrate into hippocampal 
circuitry. The expression of both non-phospho-neurofilaments and DCX in Snap-25+/− 
adult cortices and hippocampi relative to controls was comparable in amount and 
distribution, suggesting that no major alterations of neuronal migration and differentiation 
occurr when SNAP-25 is 50% reduced (Fig. 28). 
 
 
 
 
Figure 28. Immunostaining for non-phosphorilated neurofilaments and doublecortin (DCX) in P60 Snap-
25+/− and control mice. Staining for non-phospho-neurofilaments with SMI311 antibody and for DCX reveals 
no major alterations in neuronal migration or differentiation in the cortices (SMI311) and hippocampi (DCX) 
of Snap-25+/- mice relative to controls.  
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Since SNAP-25 is involved in the modulation of calcium currents, we investigated whether 
reduction of the protein expression may impact on the expression pattern of the calcium-
binding proteins involved in calcium signaling. In particular, immunostaining for the 
calcium binding proteins calbindin-D28k (CB) and calretinin (CR) were performed. As 
shown in Fig. 29, no alterations in CB or CR expression or localization in the hippocampus 
of Snap-25+/− P2 and P60 mice were observed, suggesting that SNAP-25 reduction has no 
secondary effects on calcium regulatory proteins. 
 
 
 
 
Figure 29. Evaluation of calcium-binding proteins calbindin (CB) and calretinin (CR) expression and 
localization in the hippocampi of pup (P2) and adult (P60) mice revealed no major changes in Snap-25+/- 
hippocampi at both ages compared with controls. 
 
The distribution of excitatory and inhibitory terminals in CA1 hippocampal region, 
revealed by immunostaining for vesicular glutamate transporter 1 (vGlut1) and vesicular 
GABA transporter (vGAT), showed no differences between Snap-25+/+ and Snap-25+/− 
mice (Fig. 30 K,T). Analysis of vGAT and vGlut1 positive puncta, expressed as either a 
fraction of VAMP2 positive puncta or a reciprocal ratio, was almost equivalent between 
Snap-25+/+ and Snap-25+/− mice, at least in the CA1 region of the hippocampus. Also, no 
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major difference was observed in vGlut2 distribution in the dentate gyrus of Snap-25+/+ 
and Snap-25+/− mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. No gross difference in synaptic excitatory (vGlut1, blue) and inhibitory (vGAT, red) pattern is 
detectable in CA1 hippocampal regions (K,T).  
 
 
Biochemical characterization of Snap-25+/− mouse brains  
In the adult Snap-25+/− brain the expression of SNAP-25 was about 20% lower than the 
control. To investigate whether reduced levels of SNAP-25 may affect the expression of 
other synaptic proteins, we used a biochemical approach to evaluate the expression of 
several proteins of the presynaptic and postsynaptic compartments in homogenates 
obtained from the cortices of Snap-25+/− and control mice. The expression of the 
alternative isoforms of SNAP-25, namely SNAP-23, SNAP-29 and SNAP-47, did not 
change in the cortices of heterozygous mice compared with controls. The expression of the 
presynaptic markers SV2 and vesicular glutamate transporter vGlut1 was equal in the 
cortices of heterozygous and control mice. Regarding the postsynaptic compartment, we 
detected no alterations in the expression of NMDA receptor subunits 1 and 2A (NR1 and 
NR2A, respectively),  and the post-synaptic density protein PSD95. Moreover, western 
blotting analysis did not show any variation in the expression of the calcium-binding 
protein calbindin (CB), in  agreement with the immunohystochemistry data (Fig. 31). 
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Behavioural characterization of Snap-25+/- mice 
The evidence that reduction of SNAP-25 expression may directly impact the behavioural 
phenotype derives from the analysis of the Coloboma mouse, which was identified as an 
animal model for attention-deficit hyperactivity disorder (ADHD). This mouse exhibits 
spontaneous locomotor hyperactivity and this phenotype could be reduced by the 
expression of the Snap-25 transgene (Hess et al. 1996). During the last decade, evidence 
accumulated suggesting a role for alterations in SNAP-25 expression in the onset of 
neuropsychiatric disorders such as schizophrenia, ADHD and epilepsy (Gabriel et al., 
1997; Faraone et al. 2005; Corradini et al. 2009). Concurrently, the same kind of disorders 
have been associated to alterations in calcium homeostasis (Corradini et al., 2009). 
Previous data from our lab demonstrated that SNAP-25 negatively regulates neuronal 
calcium responsiveness to stimuli (Verderio et al., 2004; Pozzi et al., 2008; Condliffe et al., 
2010) by modulating VGCCs activity. We could hypothesized that the reduction of SNAP-
25 levels and alteration in calcium homeostasis are associated in the occurence of these 
neuropsychiatric disorders. For this reason, in collaboration with the group of M. Sala 
vGLUT1 
NMDAR1 
NMDAR2A 
bIII Tub 
PSD95 
Calbindin 
SV2 
SNAP-23 
SNAP-29 
SNAP-47 
SNAP-25 
+/+   +/- 
SNAP-25 
Figure 31. Biochemical analysis of presynaptic and 
postsynaptic proteins in the homogenates of adult 
Snap-25
+/-
 and control mice. A similar expression of 
the alternative isoforms of SNAP-25 (SNAP-23, 
SNAP-47, SNAP-29), the presynaptic marker SV2, 
the postsynaptic markers NMDA receptor 1 
(NMDAR1), NMDA receptor 2A (NMDAR2A), 
vGLUT1 and PSD95 was observed. Likewise, no 
alteration in the expression of the calcium-binding 
protein calbindin was observed. βIIItubulin (bIII 
Tub) was used as loading control. 
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(University of Milano) we aimed to analyze the behaviour of Snap-25+/- mice, which 
express lower levels of the protein. 
 
Spontaneous motor activity 
Spontaneous motor activity, estimated as horizontal and vertical movement counts, was 
monitored using an activity cage (43 x 43 x 32 cm), placed in a sound-attenuated room, in 
Snap-25+/+ and Snap-25+/- mice at 7 weeks of age and in the adult. Horizontal and vertical 
activity was recorded every 10 min. As shown in Fig. 32, during the first 2-h recording 
both genotypes, at 7 weeks of age, showed a similar horizontal and vertical activity; 
however, during the following 2 h (120–240 min) Snap-25+/- mice failed to habituate, thus 
resulting more active than wildtype littermates. The increased number of counts is 
indicative of hyperactivity and higher excitability, possibly associated with the reduction of 
SNAP-25 expression. A normal locomotor activity was found in Snap-25+/- adult mice. 
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Epileptiform activity in cortices and hippocampi of Snap-25+/-mice 
As SNAP-25 is involved in the release of neurotransmitter and controls VGCC activity, we 
performed electroencephalographic recordings (EEG) of wild-type and Snap-25+/- mice in 
order to evaluate possible effects of the reduction of SNAP-25 on brain electrical activity. 
Freely moving animals were recorded for cortical and hippocampal EEG for 24 hours. The 
analysis included abnormal synchronous discharges with a minimum amplitude of twice 
the background EEG voltage and a minimum duration of 1 sec, and spike bursts separated 
by <1 sec were counted as a single discharge (Zhang et al., 2004). Recordings revealed that 
heterozygous mice displayed frequent spontaneous spikes of high amplitude both in the 
cortices and in the hippocampi, as show in the representative traces in Fig. 33. The 
increased spike frequency was observed in all tested Snap-25+/- mice, however, did not lead 
to spontaneous seizures. In only one case (a het mouse displaying 365 spikes/24 h), we 
could observe occurrence of generalized seizures following handling. The percentage of 
Snap-25+/- mice, showing abnormal EEG pattern, was significantly larger than of age-
matched control mice. Thus, reduction of SNAP-25 expression in heterozygous mice is 
associated with spontaneous epileptiform activity extended both at the cortex and at the 
hippocampus. 
  
C 
Figure 32. Activity cage. (A,B)Time-
course of  locomotor  activity evaluated  in 
4 hours. After 2h abituation Snap-25
+/- 
mice exhibited an increased horizontal and 
vertical activity. (C) Normal locomotor 
activity in Snap-25+/- adult animals.  
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Figure 33. Electroencephalographic recordings from Snap-25+/- and wild-type mice. (A,B) Representative 
cortical EEG trace (24 hr recording). (C) Magnification of representative EEG traces (30-s) from one Snap-
25+/+ and one Snap-25+/- mouse. (D) The average spike number is significantly higher in heterozygous 
respect to wild-type, as well as the percentage of mice displaying spikes.  
 
 
Increased susceptibility to kainate-induced seizures in Snap-25+/- mice 
The time-course of the behavioral response of wild-type and Snap-25+/- mice to an 
intraperitoneal administration of kainate (KA, 35 mg/kg) was evaluated over a period of 3 
hours. In all mice, this dose of KA resulted within the first 10 min in immobility and 
staring, followed by head bobbing and isolated limbic motor (Stage 4) seizures, 
characterized by forelimb clonus and rearing. Latency to the first stage 4 seizure did not 
differ from heterozygous or wild-type mice. In contrast with control animals that only 
displayed isolated limbic motor seizures, Snap-25+/- mice rapidly progressed to Stage 5 
(status epilepticus), showing continuous generalized activity lasting for about 2 h. The 
average time of Stage 5 seizure onset in Snap-25+/- mice was 45.7 ± 6.5 min. Mortality 
rate following KA administration was comparable between Snap-25+/+ and Snap-25+/- mice 
(Fig.34). Statistical analysis performed by two-way repeated measures ANOVA followed 
by Holm-Sidak post-hoc-test revealed that Snap-25+/- mice had significantly higher 
behavioral scores than Snap-25+/+ mice starting from 40 min after KA. Thus, the injection 
of KA lead to a dramatic difference of response in Snap-25+/+ and mutant animals, 
63 
 
revealed by clinical signs. Saline-injected animals of both genotypes showed no behavioral 
seizures during the whole period of observation.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34. Increased susceptibility to KA-induced seizures in Snap-25+/- mice. Progression of behavioral 
changes after systemic KA administration (35 mg/kg, i.p.) in Snap-25+/+ and Snap-25+/- mice over a 3- h 
observation period. Snap-25+/- mice showed clear signs of focal epilepsy (head bobbing), culminating in 
continuous  generalized seizures (stage 5, status epilepticus) that last for about 2 hours. Two Way Repeated 
Measures ANOVA followed by Holm-Sidak test, p<0.05 
 
Neuronal loss and mossy fiber sprouting in the hippocampus of Snap-25+/- 
mice following seizures.  
14 days after KA administration all mice were killed to evaluate histopathological changes 
in the hippocampus. We observed an extensive loss of interneurons with NPY 
immunostaining in Snap-25+/- mice respect to controls, indicating that the higher seizure 
scores of Snap-25+/- mice are paralleled by loss of hilar neurons. Moreover, we evaluated 
sprouting of mossy fibers using NPY immunohistochemistry and we found a strong 
upregulation of NPY immunoreactivity in the mossy fiber pathway of all Snap-25+/- mice 
treated with KA (Fig.35A). This result was confermed by a quantitative analysis indicating 
that NPY labeling in the CA3 stratum radiatum of KA-treated het mice was significantly 
upregulated with respect to KA-treated wt animals (Fig. 35B); on the contrary, no 
alteration in any of the KA-injected wild type animals was observed. The absence of NPY 
increased immunoreactivity in Snap-25+/- untreated mice indicate that such upregulation 
may be a consequence of KA-induced seizures and does not depend on the spontaneous 
epileptiform activity recorded by EEG. Examination of individual animals revealed a 
significant correlation between NPY staining values and the maximum KA-induced seizure 
score (Fig. 35C).  
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Figure 35. Immunohistochemistry was performed on brain slices obtained from Snap-25+/- and control mice 
14 days after kainate injection. (A) Upregulation of NPY following seizures in Snap-25+/- mice. NPY staining 
in the dentate gyrus (first panels) and CA3 region (second panels); untreated animals (third panels). (B) 
Quantification of NPY staining intensity in KA-treated mice. (C) Scatter plot showing NPY staining values 
and maximum KA-induced seizure score for each individual mouse. There is a significant correlation 
between the 2 variables (Pearson correlation coefficient=0.69, P=0.025). 
A 
B 
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Conditioned taste aversion 
Snap-25+/+ and Snap-25+/- mice were tested for implicit associative learning.  
Animals are equipped with learning mechanisms, such that their ingestive behavior can be 
modified by experience. The most important of these learning mechanisms is responsible 
for conditioned taste aversion (CTA). When ingestion of a novel taste (termed the 
conditioned stimulus or CS) is followed by transient visceral illness (termed the 
unconditioned stimulus or US) a CTA develops, demonstrated by a diminished intake of 
the CS upon subsequent encounters (Garcia and Ervin, 1968, Garcia et al., 1955 and 
Revusky and Garcia, 1970). First of all we measured in wild-type and heterozygous mice 
their ability to discriminate different tastes, by the the 2-bottle preference test. We found a 
strong preference for water over quinine and for saccharin over plain water, suggesting a 
normal taste sensitivity. There was no significant difference in HCl (0.008 M) intake 
between Snap-25+/+ and Snap-25+/- mice.  
We investigated the mice on CTA as an associative learning and memory paradigm. During 
three choice sessions 1, 2, and 3 days after aversive conditioning, Snap-25+/- mice drank 
significantly more saccharin, as expressed in percentage of total fluid intake, than Snap-
25+/+, indicating the lack of CTA and therefore an impairment in associative learning 
(Fig.36).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. Conditioned taste aversion. Snap-25+/- mice consumed more saccharine solution showing a 
significantly weaker taste aversion than Snap-25+/+ mice. 
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Novel object recognition 
The Novel Object Recognition (NOR) task is used to evaluate cognition, particularly 
recognition memory, in rodent models of CNS disorders. This test is based on the 
spontaneous tendency of rodents to spend more time exploring a novel object than a 
familiar one and it is useful for assessing impaired cognitive ability. The choice to explore 
the novel object reflects the use of learning and recognition memory. 
At first the animals were checked for sensorial parameters, and all mice appeared in health, 
displaying normal motor coordination, sensory abilities and were not aggressive. 
The task procedure consists of three phases: habituation, familiarization, and test phase. 
The results showed that during the familiarization (T1) phase both genotypes spent a 
similar amount of time to explore the 2 objects, indicating that wild-type and Snap-25+/- 
mice had the same motivation to explore the object. However, during the test phase Snap-
25+/- mice spent significantly less time exploring the novel object compared with the 
familiar one, as shown in Fig. 37 by a significant decrease of the discrimination index, thus 
indicating an impairment in recognition memory. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37. Object recognition test. Mice were allowed to explore an identical pair of objects and after 120 
min they are presented with a familiar and a new object. Snap-25+/- mice show no net preference between 
novel and familiar objects, as shown by the reduced discrimination index (**P<0.0001, unpaired t-test). 
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Sociability and social novelty 
Since reduced levels of SNAP-25 are found in the brain of schizophrenic and bipolar 
patient, we investigate the possibility that a reduction of SNAP-25 expression may impact 
the social interaction. To quantitate sociability tendencies in mice, we developed two tasks 
that measure (a) the animal‟s interest in a social stimulus (a conspecific in a wired cage 
placed in one of the outer chambers), versus a neutral stimulus (an empty wired cage 
placed in the other outer chamber) and (b) preference for a novel vs. a familiar conspecific. 
When tested for sociability, Snap-25+/+ mice behaved normally, spending longer time to 
explore the compartment with the stranger mouse than the empty cage. Conversely, Snap-
25+/- mice spent the same amount of time in the 2 compartments. Moreover, when 
subjected to a social recognition test, Snap-25+/+ mice remained close to the new or old 
stranger for the same time, suggesting altered social recognition. Both genotypes spent 
equal time in the central compartment (Fig. 38). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38. Sociability and social novelty test. Snap-25+/- mice show impaired social interaction, as they 
spend the same amount of time exploring a stranger mouse or an empty cage in a social choice paradigm. 
Social novelty (right). Snap-25+/- mice fail to show any preference for a novel mouse in a social recognition 
task. In contrast, Snap-25+/+ mice spend more time exploring the new stranger versus old stranger and center. 
 
 
 
Pharmacological treatment with antiepileptic drugs normalize the EEG 
profile and improve the cognitive defects in Snap-25+/- mice 
To better study the abnormal EEG pattern of Snap-25+/- mice, we treated the animals with 
vehicle (saline) and with different conventional antiepileptic drugs, namely valproate 
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sodium salt VLP (250 mg/kg, i.p.), ethosuximide ETO (200 mg/kg, i.p.) and 
carbamazepine CBZ (50 mg/kg, i.p.); as SNAP-25 modulates VGCC activity, animals were 
also treated with the calcium antagonist nimodipine NIMO (10mg/kg, i.p.). To investigate 
whether these different treatments were able to normalize the altered EEG profile, we 
recorded basal EEG cortical activity 30 minutes before treatment, and then over 2 hours. 
All treatments with different antiepileptic drugs significantly reduced spike activity as 
shown in Fig. 39A. We obtained the maximal effect after treatment with VLP (95% 
reduction) and ETO (80% reduction), whereas a partial but significant reduction was 
obtained with CBZ (60% reduction). Treatment with nimodipine also reduced the 
epileptiform activity, although the effect was slighter (35% reduction) than with other 
drugs. The mean number of spikes was significantly reduced in Snap-25+/- mice treated 
with VLP (Fig. 39C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39. Antiepileptic drugs normalize the EEG profile. (A) Treatment with VLP (250 mg/kg), 
ethosuximide (ETO) (200 mg/kg), carbamazepine (CBZ) (50 mg/kg), and nimodipine (NIMO) (10 mg/kg) to 
Snap-25+/− mice significantly reduces spike activity. (B) EEG recording of one representative Snap-25+/- 
mouse treated with VLP showing a decreased spike activity in comparison to one Snap-25+/+ mouse. (C) The 
mean number of spikes recorded for 60 min in Snap-25+/- mice is significantly reduced by VLP compared 
with vehicle.  
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Given the beneficial consequence produced by VLP in the EEG profile, we also analyzed 
the effects of this treatment on the behavioural tests.  
VLP, given 2 h before test performance, reversed the cognitive deficit of Snap-25+/- mice in 
the object recognition task.  CTA impairment, noted in heterozygous mice, was fully 
reversed by pretreatment with VLP, given immediately before HCl exposure; moreover this 
antiepileptic drug normalized the defects in social memory, although it was ineffective in 
restoring sociability (Fig. 40). 
It has been reported that VPL can interfere with learning and memory processes both in 
experimental models (Wu et al., 2002; Sgobio et al., 2010) and patients (Mula and Trimble, 
2009); in agreement with these evidence we observed a slight, but not significant, 
worsening of cognitive abilities in Snap-25+/+ mice treated with VLP (not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40. Antiepileptic drugs reverse learning defects in Snap-25+/- mice. (D)VLP reverses the defect in 
object recognition test. The reduced discrimination index, found in Snap-25+/- mice, is reversed by 
pretreatment with VLP given i.p. at the dose of 250 mg/kg, 20 min before T1 trial. (E) VLP reverses CTA 
impairment. (F) Effect of VLP in sociability in Snap-25+/- mice. VLP do not reverse the impaired social 
interaction. (G) VLP is effective in improving putative social memory. 
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FUNCTIONAL STUDY OF A POLYMORPHISM IN THE 
GENE OF SNAP-25 
Cognitive ability is currently considered as a polygenic trait influenced by many genes 
that, in turn, may interact with each other and with environmental factors.  
Previous studies have reported a strong association between three SNPs in  the Snap-25 
gene and intelligence. These SNPs, namely rs363039, rs363050 and rs363043, all located 
on intron 1, showed association in the same direction and the same order of magnitude, 
although strongest evidence was found for SNP rs363050. SNPs located in regulatory 
region (promoters, UTRs, introns) may have a significant influence on the expression level 
of a gene.  
Aiming to define whether these polymorphisms play a role in Snap-25 gene expression, we 
conducted an analysis of the functional effects of the polymorphism (rs363050) on 
transcriptional activity, by means of luciferase reporter gene. A series of plasmids, in which 
the cassette containing the SNP (parental or minor allele) was inserted upstream or 
downstream  the TK promoter in pGL4 basic vector, was originated. Plasmids were 
transiently transfected in human neuroblastoma SH-SY5Y cell line, and the activity of the 
constructs was compared with that of the plasmid lacking the cassette. The presence of the 
parental allele (A), when cloned upstream the TK promoter (construct rs363050A-TK-luc), 
did not increase the promoter activity, while the presence of the minor allele (G; construct 
rs363050G-TK-luc) significantly reduced the transcription of luciferase by 2-fold. When 
the cassette was inserted downstream the luciferase reporter gene, both constructs (TK-luc-
rs363050A and TK-luc-rs363050G) showed a dramatic decrease in the capability of 
driving the expression of the reporter gene with respect to the construct with the cassette 
cloned upstream the TK promoter. However, the reduced transcription capability of the 
minor allele compared with the parental allele was confirmed (Fig. 41). 
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Figure 41. Schematic representation of the reporter constructs used in the luciferase assay. SY5Y cells were 
transiently transfected with the constructs indicated on the left, and the luciferase assays were performed 48 
hr later. The bars represent the relative expression levels luc/ren (firefly luciferase/renilla luciferase). Data 
represent means ± SD. The presence of the minor allele (G), upstream or downstream the TK promoter, 
significantly decreases the luciferase transcription. 
 
These findings suggest that the region encompassing the rs363050 SNP contains a 
regulatory element whose function is dependent on its position; furthermore, the presence 
of the minor allele may influence the transcription of the Snap-25 gene. 
In order to study more in detail the regulatory activity of the rs363050 SNP, a small 
oligonucleotide encompassing the SNP was cloned in multiple copies upstream the TK 
promoter. As shown in Fig. 42, the presence of 4 copies of rs363050 SNP cassette (4X A-
TK-luc)  resulted in a slight increase in the promoter activity, whereas 4 copies of the 
minor allele (4X G-TK-luc) reduced the promoter activity in a manner equivalent to that of 
rs363050-G-TK-luc construct. Taken together, these results support the evidence that the 
rs363050 polymorphism might have a role in modulating Snap-25 gene expression levels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. Effects of four copies of rs363050 SNP cassette (parental or minor allele) on promoter activity  in 
SY5Y cells. Data represent means ± SD of  luc/ren ratio. 
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The polymorphic sequence was analysed in silico for putative transcription factor binding 
sites using the Genomatix program (Genomatix Software GmbH, Munich, Germany). The 
analysis revealed that the polymorphic site disrupts a putative binding site for the 
transcription factor AP-1. AP-1 is ubiquitously expressed and its activity is induced by 
physiological stimuli and environmental insults. It is constituted by Jun (c-Jun, JunB, 
JunD) homodimers, or Jun heterodimers with Fos (c-Fos, FosB, Fra-1, Fra-2) or ATF 
(activating transcription factor) proteins. AP-1 regulates a wide range of cellular processes, 
including cell proliferation, death, survival and differentiation. 
To assess the possible interaction between the polymorphic site and AP-1, a gelshift assay 
was performed. An oligonucleotide encompassing the region of Snap-25 that included the 
putative binding site for AP-1 (parental allele, rs363050 A) was incubated in the presence 
of SH-SY5Y nuclear extract, resulting in the formation of three retarded complexes. The 
specificity of these complexes was tested by competition in the presence of a molar excess 
of the same cold oligonucleotide (100x and 300x), (lanes 2 and 3). A molar excess of a 
cold oligonucleotide bearing the minor allele (G instead of A, lanes 4 and 5) was unable to 
compete with any of the three complexes, suggesting that specific factors recognizing the 
sequence bearing the parental allele can bind this region.  
To test whether these factors belong to the AP-1 family of transcription factors, the nuclear 
extract was pre-incubated with antibodies directed against Jun or Fos. As shown in fig. 43 
(lanes 6 and 7), no ultra-retarded bands were observed, indicating that the transcription 
factor AP-1 is probably not involved in the binding of this region.  
In conclusion, the presence of the cassette bearing the parental allele did not increase the 
basal activity of a heterologous promoter, whereas the minor allele resulted in a reduction 
of the transcription capability. This indicates that the presence of the minor versus the 
parental allele may result in the impairment of the binding of factors involved in the 
modulation of Snap-25 gene expression,  or in the binding of other factors, different from 
those recognizing the parental sequence, acting as repressors. Further characterization of 
these factors is required in order to analyse more in depth the effects of the presence of the 
minor polymorphic allele.  
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Figure 43. Molecular analysis by gelshift of the putative binding site for AP-1. On the left, the arrows  
indicate the retarded complexes formed upon incubation of the labeled probe with SY5Y nuclear extract 
(lane 1). Competition experiments were performed in the presence of a molar excess (100x or 300x) of the 
cold oligonucleotide bearing the parental allele (lanes 2, 3) or the minor allele (lanes 4, 5).  No ultra-retarded 
bands were observed when the nuclear extract was pre-incubated with the anti-Fos and anti-Jun antibodies 
(lanes 6, 7).   
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DISCUSSION 
SNAP-25 is a fundamental component of the SNARE complex responsible for synaptic 
vesicle exocytosis. Besides participating in exocytosis, SNAP-25 also modulates various 
voltage-gated calcium channels (VGCCs), interacting through a region known as synaptic 
protein interaction (synprint). In the last years, evidence accumulated suggesting a 
differential expression of SNAP-25 in neuronal subpopulations; in particular, adult 
glutamatergic neurons express high levels of SNAP-25, while mature GABAergic 
terminals virtually lack immunoreactivity for the protein (Verderio et al., 2004; Frassoni et 
al., 2005; Garbelli et al., 2008; Bragina et al., 2007; Mandolesi et al., 2009). It has been 
recently demonstrated that SNAP-25 negatively controls neuronal calcium responsiveness 
to depolarization, through voltage-gated calcium channel inhibition upon phosphorylation 
on the residue Ser187 (Pozzi et al., 2008). Furthermore, a recent paper of our group 
(Condliffe et al., 2010) showed that endogenous SNAP-25 levels negatively regulate native 
VGCC properties in glutamatergic neurons, which displayed significantly lower VGCC 
current densities, enhanced inactivation rates and shifts in the voltage-dependence of 
activation and steady-state voltage-dependent inactivation curves relative to GABAergic 
neurons, which express lower levels of the protein. Moreover, silencing of endogenous 
SNAP-25 in glutamatergic neurons increased VGCC current density, while over-
expressing SNAP-25 in GABAergic neurons reduced inward VGCC current and 
inactivation kinetics. Furthermore, VGCC current densities in glutamatergic neurons from 
Snap-25
+/-
 mice were significantly elevated compared with wild type glutamatergic 
neurons, (Condliffe et al., 2010). Consistently, Snap-25
+/-
 neurons displayed enhanced 
evoked glutamatergic neurotransmission, and shifted from paired pulse facilitation to 
paired pulse depression, thus indicating that reduced levels of SNAP-25 may induce an 
increase in presynaptic release probability (Antonucci et al., submitted). 
 
In the last years, altered levels of SNAP-25 expression have been associated to different 
neurological and neuropsychiatric conditions. Case-control and family based studies 
associated SNAP-25 with Attention Deficit-Hyperactivity Disorder (ADHD; Barr et al., 
2000; Kustanovich et al., 2003; Mill et al., 2004; Faraone et al., 2005; Feng et al., 2005); in 
line with this, single nucleotide polymorphisms (SNPs) in the Snap-25 gene have been 
linked to inattentive hyperactivity in a group of ADHD children (Zhang et al., 2010), and 
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associated with hyperactivity in autism spectrum disorders (Guerini et al., 2011). 
Moreover, reduction of SNAP-25 expression has been described in psychiatric patients. In 
particular, reduced levels of SNAP-25 have been described in the hippocampus (Young et 
al., 1998; Thompson et al., 2003) and in the frontal lobe (Thompson et al., 1998) of 
patients with schizophrenia, while other modifications of SNAP-25 levels occur in the 
brain of bipolar patients (Fatemi et al., 2001; Scarr et al., 2006). The demonstration that 
SNAP-25 expression is altered in psychiatric patients suggests that variations in SNAP-25 
levels may have a pathogenic effect, possibly affecting synaptic function and network 
activity. Up to now, the only evidence linking SNAP-25 reduction to an altered phenotype 
derives from the Coloboma mutant mouse, that is heterozygous (Cm/+) for a neutron 
irradiation induced, semi-dominant deletion spanning 4.6 Mb on mouse chromosome 2, 
that encompasses 10-12 genes including Snap-25 (Hess et al., 1996), thus resulting in 50% 
reduction of SNAP-25 expression. The Coloboma mice is a model for ADHD (Wilson 
2000; reviewed in Faraone et al., 2005; Russell 2007), and it is characterized by an 
hyperactive phenotype, which is reduced by the expression of the Snap-25 transgene (Hess 
et al., 1996). Given that the deleted region in this mutant mouse comprises several genes, 
including genes for phospholipase C beta-1 (Plcb1), coloboma (cm), Plcb4, and Jag1, this 
model maynot be suited for investigating the neurophysiological and behavioural 
phenotype induced by reduction of SNAP-25 levels.  
For this reason, here we aimed at evaluating the possible effects of SNAP-25 reduction in a 
mouse model in which only SNAP-25 expression is reduced. For this purpose, we 
performed morphological, biochemical and behavioural studies in the Snap-25 
heterozygous mouse. The Snap-25 gene is a single gene spanning more than 80 kb and the 
polypeptide is encoded by eight different exons spaced by quite large introns (Bark, 1993). 
Differential splicing of exon 5 results in the expression of two transcripts, SNAP-25a or 
SNAP-25b; these two isoforms are developmentally regulated, with SNAP-25b being 
mostly expressed in the adult. In the Snap-25
+/− 
mutant mouse, the region containing both 
exon 5a and 5b was disrupted by the insertion of a PGKneo cassette, thus reducing by 50% 
both alternatively spliced isoforms of the protein. Differently from the Coloboma mutant, 
in the Snap-25
+/−
 mouse only the expression of SNAP-25 is affected. Up to now all the 
analysis for quantifying the protein expressionin Snap-25
+/−
 mouse have been carried out 
at embryonic day (E)17.5, when a 50% reduction of the protein was demonstrated 
(Washbourne et al., 2000). In order to confirm SNAP-25 reduction during brain 
development, we analyzed the levels of the protein during different developmental stages, 
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from E18 embryo to adult mouse (30 days old, P30). We observed a progressive increase 
of the protein expression during development, which was not accompanied by a parallel 
increase in SNAP-25 mRNA levels, suggesting that post-transcriptional mechanisms are 
activated during postnatal development and are responsible for a compensation in protein 
expression. The molecular basis for SNAP-25 expression increase are not clarified yet. 
Since Snap-25
+/-
 mice are characterized by an abnormal EEG profile, one could 
hypothesize that the increase in protein synthesis may derive from an activity-dependent 
regulation of the protein transcription. This possibility needs to be tested in detail. 
Whatever the mechanisms involved, it is however interesting that hyperactivity, which is 
associated to reduced protein expression, tends to disappear in adult Snap-25
+/-
 mice 
(Corradini et al., 2012). This situation closely reminds what described for ADHD, where 
symptoms continue from childhood to adulthood only in a percentage of patients, 
disappearing in the vast majority of cases. 
As some neuropsychiatric disorders may arise as consequence of malformations, tumours 
or inflammation, we evaluated the possible effects of SNAP-25 reduction on brain 
anatomy. No major morphological and structural alterations were observed in the pups 
(postnatal day 2, P2) or in the adult brain (postnatal day 60, P60), thus indicating that the 
reduction of SNAP-25 expression does not lead to altered brain morphology. Also, we did 
not detect defects in neurogenesis or neuronal maturation, evaluated by means of 
immunostaining for the non-phosphorylated neurofilaments and the neurogenesis marker 
doublecortin. As SNAP-25 is involved in modulation of calcium currents, we evaluated the 
expression of two calcium binding proteins, namely calbinin-D28k and calretinin, in the 
heterozygous and wild-type hippocampi. Calbindin and calretinin are highly expressed in 
most neuronal populations in the central nervous system and they participate in the control 
of calcium concentration at the synapse, thus representing a possible mechanism of control 
of release probability and synaptic plasticity. We did not observe alterations ofcalbindin 
orcalreti nin expression or localization in the hippocampi of P2 and P60 Snap-25
+/− 
mice, 
compared with wild-type controls, thus excluding the possibility that reduced SNAP-25 
expression may lead to altered calcium homeostasis through mechanisms other than the 
modulation of VGCCs. 
Different homologous forms of SNAP-25 are present in neuronal and non-neuronal cells, 
namely SNAP-23, SNAP-29 and SNAP-47. Similarly to SNAP-25, these different 
isoforms can form a SNARE complex with different partners (Ravichandran et al., 1996; 
Hohenstein, 2001; Holt, 2006). Moreover, SNAP-29 was suggested to modulate synaptic 
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transmission (Su et al., 2001; Pan et al., 2005). In order to evaluate possible alterations of 
SNAP-23, SNAP-29 and SNAP-47 expression caused by reduction of SNAP-25, we 
performed biochemical experiments on cortical homogenates obtained from Snap-25
+/−
 
and wild-type mouse brains. We did not find altered expression for any of these proteins, 
which excludes the possibility that SNAP-23, -29 and -47 expression may vary upon 
reduction of SNAP-25 expression constituting a compensatory mechanism. 
Snap-25
+/- 
mice were then analysed for several behavioural tasks in order to characterize 
their phenotype. Like coloboma mutant mice (Hess et al., 1996), we found  a hyperactive 
phenotype  in the Snap-25
+/−
 mice, measured in the activity cage. It has been described that 
SNAP-25 reductions lead to the onset of absence epilepsy in the coloboma mouse model, 
which were preceded by intracellular calcium elevations (Zhang et al., 2004). We then 
evaluated the possibility that Snap-25
+/− 
mice display an epileptic phenotype. Analysis of 
the EEG recordings showed frequent spontaneous spikes both in the cortices and in the 
hippocampi of heterozygous mice. Such abnormal EEG was never observed in the wild-
type control animals. However, the presence of spikes did not lead to an overt epileptic 
phenotype, except than in sporadic cases. Moreover, heterozygous mice showed a higher 
susceptibility to kainate-induced seizures compared to controls, which was accompanied, 
14 days after kainate injection, by a strong sprouting of mossy fibers, that is a marker  of 
epileptogenesis after kainate injection. Taken together, these data suggest that reduction of 
SNAP-25 expression affects network activity, leading to hyperexcitability. Interestingly, 
the incidence of epilepsy is 2.7 times higher in ADHD children (Davis et al., 2010), and 
patients with schizophrenia are 6 times more likely to develop epilepsy than the controls 
(Chang et al., 2011). Although the mechanismsby which SNAP-25 reduction impacts 
network excitability still remain unclear, enhanced calcium currents selectively occurring 
in glutamatergic but not GABAergic neurons (Condliffe et al., 2010) may generate an 
excitatory/inhibitory imbalance which can eventually result in altered EEG activity. 
Besides electroencephalographic abnormalities, Snap-25
+/− 
mice display an impairment in 
associative learning and recognition memory, indicated by the lack of conditioned taste 
aversion, and deficits in the novel object and social recognition tasks, respectively.  
Furthermore, reduction of SNAP-25 expression also impact social interaction; indeed our 
results revealed an altered social behavior in Snap-25
+/− 
mice respect to controls as 
demonstrated by deficits in the test for social preference. 
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We reasoned that the abnormal EEG profile observed in SNAP-25
+/-
 mice could contribute 
to the learning and memory defects. Indeed, the cognitive effects of epileptiform 
discharges are very well known and may be very similar to those observed upon short 
epileptic seizures (Aarts et al., 1984). Consistently, a decline in IQ scores was reported in 
patients with frequent episodes of epileptiform discharges (Aldenkamp et al., 2005; 
Aldenkamp et al., 2010). 
Treatment with antiepileptic drugs, or with the calcium antagonist nimodipine, largely 
normalized the altered EEG profile of Snap-25
+/−
 mice, the larger beneficial effects 
produced by valproate and ethosuximide, i.e. drugs effective at controlling absence 
seizures. Even more interestingly, we demonstrated that treatment with VLP rescued 
associative and recognition memory defects, while it did not revert the deficit observed in 
social interaction. Notably, carbamazepine has been reported to exert a positive effect on a 
child with ADHD and subclinical EEG discharges without seizures (Laporte et al, 2002), 
while treatment with VLP appeared to ameliorate ADHD symptoms in Fragile X 
Syndrome boys (Torrioli et al., 2008). These data therefore indicate that reductions in 
SNAP-25 expression may produce  a hyperexcitable background, resulting in altered EEG 
profile and in the occurrence of cognitive deficits, both of which can be efficaciously 
treated by antiepileptic drugs. 
 
A number of single nucleotide polymorphisms (SNPs) have been implicated in different 
neuropsychiatric and neurological disorders. In particular, recent evidence have suggested 
an association between SNPs in the Snap-25 gene and ADHD (Barr et al., 2000; Mill et al., 
2004; Feng et al., 2005), schizophrenia (Tachikawa et al., 2001; Spellmann et al., 2008), 
bipolar disorder (Eitain et al., 2010) and autism (Guerini et al., 2011). Two SNPs 
(rs363050 and rs363039) in the Snap-25 gene have been associated with variations in 
intellectual abilities in two independent Dutch samples (Gosso et al., 2006 and 2008). 
SNPs in regulatory regions may result in functional changes in the gene product and may 
play a role in the regulation of gene expression. Based on the results we have obtained, 
showing the occurrence of cognitive disabilities in mice expressing reduced levels of 
SNAP-25, we conducted a functional analysis on one of these SNPs, rs363050, which 
associates with low performance IQ (Gosso et al., 2006) and is located on  intron 1 of the 
Snap-25 gene, to investigate whether the presence of the parental or minor allele may 
affect the expression of SNAP-25. Here we demonstrate that the presence of the minor 
allele, inserted either upstream or downstream the promoter, significantly decreases the 
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transcription capability, although we did not obtain an amplification of this effect in the 
promoter activity when we inserted 4 copies of the minor allele. 
On the other hand, the presence of the cassette bearing the parental allele did not increase 
the basal activity of an heterologous promoter. The presence of the minor versus the 
parental allele may thus result in the impairment of the binding of factors involved in the 
modulation of the Snap-25 gene expression level, or in the binding of other factors, unlike 
the ones that recognize the sequence of the parental allele, acting as repressors. Due to the 
importance that the presence of the minor allele can have on SNAP-25 expression level, a 
further characterization of these factors is mandatory. Interestingly, a higher frequency of 
the rs363050 polymorphism has been recently associated with intellectual disability (ID) 
cases compared to controls (Rizzi et al., 2012).  
Our data offer a logical frame for these findings, by directly linking polymorphisms in the 
Snap-25 gene, reduction of the protein expression, generation of subclinical epileptiform 
discharges and learning disabilities. They also suggest that human genetic variations, 
resulting in reduced protein expression, may create a background susceptible to functional 
failures, which in turn may lead to network hyperexcitability. Finally, we demonstrate the 
beneficial effect of antiepileptic drugs in ameliorating the abnormal excitability and the 
cognitive defects linked to reduction of SNAP-25 expression, thus offering the possibility 
of new therapeutic strategies. 
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